ONTOLOGY REPORT - ANNOTATIONS
| Term: | p-block element atom |
|
| Accession: | CHEBI:33560
|
browse the term
|
| Definition: | Any main group element atom belonging to the p-block of the periodic table. |
| Synonyms: | related_synonym: | p-block element; p-block elements |
|
|
1,2-dibromoethane
|
| G |
Arid3a |
AT rich interactive domain 3A (Bright like) |
|
increases expression |
ISO |
7 |
11,269,055 |
11,290,551 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases metabolic processing |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases metabolic processing |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Ecm1 |
extracellular matrix protein 1 |
|
decreases expression |
ISO |
2 |
190,525,156 |
190,530,323 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
decreases expression |
ISO |
13 |
96,722,973 |
96,752,940 |
RGD:6480464 |
CTD |
| G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
increases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ggt1 |
gamma-glutamyltransferase 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
increases activity |
ISO |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
multiple interactions |
ISO |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
increases activity |
EXP |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
affects response to substance |
EXP |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
multiple interactions |
EXP |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Lef1 |
lymphoid enhancer binding factor 1 |
|
decreases expression |
ISO |
2 |
228,550,263 |
228,673,131 |
RGD:6480464 |
CTD |
| G |
Mapk10 |
mitogen activated protein kinase 10 |
|
increases expression |
ISO |
14 |
7,719,595 |
8,010,694 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
affects binding |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
increases response to substance |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Odc1 |
ornithine decarboxylase 1 |
|
increases activity |
EXP |
6 |
41,309,211 |
41,315,796 |
RGD:6480464 |
CTD |
| G |
Pld3 |
phospholipase D family, member 3 |
|
increases expression |
ISO |
1 |
82,612,833 |
82,624,575 |
RGD:6480464 |
CTD |
| G |
Ppp1r1c |
protein phosphatase 1, regulatory (inhibitor) subunit 1C |
|
decreases expression |
ISO |
3 |
62,519,426 |
62,622,517 |
RGD:6480464 |
CTD |
| G |
St7l |
suppression of tumorigenicity 7-like |
|
decreases expression |
ISO |
2 |
200,125,720 |
200,198,472 |
RGD:6480464 |
CTD |
| G |
Tcfl5 |
transcription factor-like 5 (basic helix-loop-helix) |
|
increases expression |
ISO |
3 |
169,712,264 |
169,731,865 |
RGD:6480464 |
CTD |
| G |
Tp63 |
tumor protein p63 |
|
increases expression |
ISO |
11 |
76,900,622 |
77,200,251 |
RGD:6480464 |
CTD |
| G |
Tph1 |
tryptophan hydroxylase 1 |
|
increases expression |
ISO |
1 |
97,186,071 |
97,207,551 |
RGD:6480464 |
CTD |
| G |
Trpv2 |
transient receptor potential cation channel, subfamily V, member 2 |
|
increases expression |
ISO |
10 |
48,764,894 |
48,786,150 |
RGD:6480464 |
CTD |
1,4-dibromobenzene
|
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
2,6-dibromophenol
|
| G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
|
decreases expression |
ISO |
7 |
113,043,365 |
113,049,779 |
RGD:6480464 |
CTD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
1 |
251,965,458 |
251,971,449 |
RGD:6480464 |
CTD |
| G |
Cyp21a1 |
cytochrome P450, family 21, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
20 |
4,125,357 |
4,128,518 |
RGD:6480464 |
CTD |
| G |
Hsd17b1 |
hydroxysteroid (17-beta) dehydrogenase 1 |
|
decreases expression |
ISO |
10 |
90,094,249 |
90,096,451 |
RGD:6480464 |
CTD |
| G |
Hsd17b4 |
hydroxysteroid (17-beta) dehydrogenase 4 |
|
decreases expression |
ISO |
18 |
45,157,435 |
45,251,606 |
RGD:6480464 |
CTD |
| G |
Hsd3b2 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 |
|
increases expression |
ISO |
2 |
193,500,916 |
193,507,633 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
decreases expression |
ISO |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
3,3',5,5'-tetrabromobisphenol A
|
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
EXP |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases activity |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
increases secretion |
ISO |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Atp2a1 |
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 |
|
decreases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl3 |
B-cell CLL/lymphoma 3 |
|
increases expression |
EXP |
1 |
79,122,801 |
79,137,035 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
increases activity |
ISO |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Cd86 |
CD86 molecule |
|
increases expression |
ISO |
11 |
66,215,233 |
66,238,882 |
RGD:6480464 |
CTD |
| G |
Chrna4 |
cholinergic receptor, nicotinic, alpha 4 (neuronal) |
|
multiple interactions |
ISO |
3 |
170,171,214 |
170,185,998 |
RGD:6480464 |
CTD |
| G |
Chrna4 |
cholinergic receptor, nicotinic, alpha 4 (neuronal) |
|
multiple interactions |
ISO |
3 |
170,171,214 |
170,185,998 |
RGD:6480464 |
CTD |
| G |
Chrnb2 |
cholinergic receptor, nicotinic, beta 2 (neuronal) |
|
multiple interactions |
ISO |
2 |
181,961,373 |
181,969,581 |
RGD:6480464 |
CTD |
| G |
Chrnb2 |
cholinergic receptor, nicotinic, beta 2 (neuronal) |
|
multiple interactions |
ISO |
2 |
181,961,373 |
181,969,581 |
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
decreases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp21a1 |
cytochrome P450, family 21, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
20 |
4,125,357 |
4,128,518 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
affects binding |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
decreases expression |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
affects binding |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Gabra1 |
gamma-aminobutyric acid (GABA) A receptor, alpha 1 |
|
multiple interactions |
ISO |
10 |
27,258,813 |
27,313,725 |
RGD:6480464 |
CTD |
| G |
Gabrb2 |
gamma-aminobutyric acid (GABA) A receptor, beta 2 |
|
multiple interactions |
ISO |
10 |
27,602,085 |
27,819,145 |
RGD:6480464 |
CTD |
| G |
Gabrg2 |
gamma-aminobutyric acid (GABA) A receptor, gamma 2 |
|
multiple interactions |
ISO |
10 |
27,037,561 |
27,126,074 |
RGD:6480464 |
CTD |
| G |
Hspa1l |
heat shock protein 1-like |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hspa2 |
heat shock protein 2 |
|
decreases expression |
ISO |
6 |
99,000,541 |
99,003,041 |
RGD:6480464 |
CTD |
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
decreases expression |
ISO |
9 |
53,884,193 |
53,895,043 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases secretion |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
increases expression |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases secretion |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
decreases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
decreases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
P4hb |
prolyl 4-hydroxylase, beta polypeptide |
|
multiple interactions |
EXP |
10 |
109,950,221 |
109,961,716 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
increases expression |
ISO |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
increases expression |
ISO |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
multiple interactions |
ISO |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ryr1 |
ryanodine receptor 1 (skeletal) |
|
increases activity |
ISO |
1 |
84,116,098 |
84,254,503 |
RGD:6480464 |
CTD |
| G |
Ryr1 |
ryanodine receptor 1 (skeletal) |
|
multiple interactions |
ISO |
1 |
84,116,098 |
84,254,503 |
RGD:6480464 |
CTD |
| G |
Serpina7 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7 |
|
multiple interactions |
ISO |
X |
126,739,203 |
126,744,763 |
RGD:6480464 |
CTD |
| G |
Sox9 |
SRY (sex determining region Y)-box 9 |
|
decreases expression |
ISO |
10 |
102,392,187 |
102,394,256 |
RGD:6480464 |
CTD |
| G |
Sult1a1 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
|
multiple interactions |
ISO |
1 |
185,829,205 |
185,832,725 |
RGD:6480464 |
CTD |
| G |
Tff1 |
trefoil factor 1 |
|
increases expression |
ISO |
20 |
9,526,674 |
9,530,534 |
RGD:6480464 |
CTD |
| G |
Tff1 |
trefoil factor 1 |
|
increases expression |
ISO |
20 |
9,526,674 |
9,530,534 |
RGD:6480464 |
CTD |
| G |
Thra |
thyroid hormone receptor alpha |
|
multiple interactions |
ISO |
10 |
87,514,443 |
87,542,306 |
RGD:6480464 |
CTD |
| G |
Thra |
thyroid hormone receptor alpha |
|
multiple interactions |
ISO |
10 |
87,514,443 |
87,542,306 |
RGD:6480464 |
CTD |
| G |
Thra |
thyroid hormone receptor alpha |
|
multiple interactions |
ISO |
10 |
87,514,443 |
87,542,306 |
RGD:6480464 |
CTD |
| G |
Thra |
thyroid hormone receptor alpha |
|
multiple interactions |
ISO |
10 |
87,514,443 |
87,542,306 |
RGD:6480464 |
CTD |
| G |
Thra |
thyroid hormone receptor alpha |
|
increases activity |
EXP |
10 |
87,514,443 |
87,542,306 |
RGD:6480464 |
CTD |
| G |
Thrb |
thyroid hormone receptor beta |
|
multiple interactions |
ISO |
15 |
9,282,845 |
9,345,506 |
RGD:6480464 |
CTD |
| G |
Thrb |
thyroid hormone receptor beta |
|
multiple interactions |
ISO |
15 |
9,282,845 |
9,345,506 |
RGD:6480464 |
CTD |
| G |
Thrb |
thyroid hormone receptor beta |
|
multiple interactions |
ISO |
15 |
9,282,845 |
9,345,506 |
RGD:6480464 |
CTD |
| G |
Thrb |
thyroid hormone receptor beta |
|
multiple interactions |
ISO |
15 |
9,282,845 |
9,345,506 |
RGD:6480464 |
CTD |
| G |
Thrb |
thyroid hormone receptor beta |
|
multiple interactions |
ISO |
15 |
9,282,845 |
9,345,506 |
RGD:6480464 |
CTD |
| G |
Thrb |
thyroid hormone receptor beta |
|
multiple interactions |
ISO |
15 |
9,282,845 |
9,345,506 |
RGD:6480464 |
CTD |
| G |
Thrb |
thyroid hormone receptor beta |
|
increases activity |
EXP |
15 |
9,282,845 |
9,345,506 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases secretion |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Ttr |
transthyretin |
|
affects binding |
ISO |
18 |
12,406,571 |
12,413,680 |
RGD:6480464 |
CTD |
| G |
Ttr |
transthyretin |
|
multiple interactions |
ISO |
18 |
12,406,571 |
12,413,680 |
RGD:6480464 |
CTD |
| G |
Ttr |
transthyretin |
|
multiple interactions |
ISO |
18 |
12,406,571 |
12,413,680 |
RGD:6480464 |
CTD |
3,5-dibromo-4-hydroxybenzonitrile
|
| G |
Gja1 |
gap junction protein, alpha 1 |
|
decreases activity |
EXP |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Ttr |
transthyretin |
|
affects binding |
EXP |
18 |
12,406,571 |
12,413,680 |
RGD:6480464 |
CTD |
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
|
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
decreases activity |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Aco2 |
aconitase 2, mitochondrial |
|
multiple interactions |
ISO |
7 |
120,223,788 |
120,266,944 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases activity |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
4-nitrobenzyl bromide
|
| G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
|
increases activity |
ISO |
17 |
77,034,737 |
77,081,406 |
RGD:6480464 |
CTD |
8-bromo-3',5'-cyclic AMP
|
| G |
Agr2 |
anterior gradient 2 homolog (Xenopus laevis) |
|
multiple interactions |
ISO |
6 |
54,695,633 |
54,716,858 |
RGD:6480464 |
CTD |
| G |
Akap7 |
A kinase (PRKA) anchor protein 7 |
|
multiple interactions |
ISO |
1 |
20,573,215 |
20,704,564 |
RGD:6480464 |
CTD |
| G |
Angpt1 |
angiopoietin 1 |
|
multiple interactions |
ISO |
7 |
78,195,504 |
78,451,471 |
RGD:6480464 |
CTD |
| G |
Anxa8 |
annexin A8 |
|
multiple interactions |
ISO |
16 |
9,715,644 |
9,730,584 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
multiple interactions |
ISO |
10 |
71,605,791 |
71,610,330 |
RGD:6480464 |
CTD |
| G |
Cga |
glycoprotein hormones, alpha polypeptide |
|
increases expression |
EXP |
5 |
51,538,259 |
51,550,324 |
RGD:6480464 |
CTD |
| G |
Clic3 |
chloride intracellular channel 3 |
|
multiple interactions |
ISO |
3 |
3,622,894 |
3,624,805 |
RGD:6480464 |
CTD |
| G |
Col7a1 |
collagen, type VII, alpha 1 |
|
multiple interactions |
ISO |
8 |
113,971,207 |
114,003,445 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
increases activity |
ISO |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
251,965,458 |
251,971,449 |
RGD:6480464 |
CTD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
1 |
251,965,458 |
251,971,449 |
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
increases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Fshb |
follicle stimulating hormone, beta polypeptide |
|
increases expression |
EXP |
3 |
92,569,344 |
92,571,254 |
RGD:6480464 |
CTD |
| G |
Fshb |
follicle stimulating hormone, beta polypeptide |
|
increases expression |
EXP |
3 |
92,569,344 |
92,571,254 |
RGD:6480464 |
CTD |
| G |
Fshb |
follicle stimulating hormone, beta polypeptide |
|
multiple interactions |
EXP |
3 |
92,569,344 |
92,571,254 |
RGD:6480464 |
CTD |
| G |
Hsd17b1 |
hydroxysteroid (17-beta) dehydrogenase 1 |
|
multiple interactions |
ISO |
10 |
90,094,249 |
90,096,451 |
RGD:6480464 |
CTD |
| G |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
|
multiple interactions |
ISO |
19 |
47,729,519 |
47,802,933 |
RGD:6480464 |
CTD |
| G |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
|
increases expression |
ISO |
19 |
47,729,519 |
47,802,933 |
RGD:6480464 |
CTD |
| G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
|
multiple interactions |
ISO |
2 |
193,337,342 |
193,346,799 |
RGD:6480464 |
CTD |
| G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
|
increases expression |
ISO |
2 |
193,337,342 |
193,346,799 |
RGD:6480464 |
CTD |
| G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
|
increases secretion |
ISO |
14 |
87,950,222 |
87,955,289 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
increases expression |
EXP |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Ncf2 |
neutrophil cytosolic factor 2 |
|
multiple interactions |
ISO |
13 |
67,806,516 |
67,834,105 |
RGD:6480464 |
CTD |
| G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
|
increases expression |
ISO |
7 |
140,012,807 |
140,020,590 |
RGD:6480464 |
CTD |
| G |
Pde3a |
phosphodiesterase 3A, cGMP inhibited |
|
increases expression |
EXP |
4 |
178,658,896 |
178,930,417 |
RGD:6480464 |
CTD |
| G |
Pecam1 |
platelet/endothelial cell adhesion molecule 1 |
|
multiple interactions |
ISO |
10 |
96,056,220 |
96,057,232 |
RGD:6480464 |
CTD |
| G |
Pld1 |
phospholipase D1 |
|
multiple interactions |
ISO |
2 |
115,306,940 |
115,460,518 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases secretion |
ISO |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases expression |
ISO |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
multiple interactions |
ISO |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases expression |
ISO |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ror1 |
receptor tyrosine kinase-like orphan receptor 1 |
|
multiple interactions |
ISO |
5 |
120,746,419 |
121,098,205 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
multiple interactions |
ISO |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Sftpb |
surfactant protein B |
|
multiple interactions |
ISO |
4 |
105,609,410 |
105,618,452 |
RGD:6480464 |
CTD |
| G |
Sftpc |
surfactant protein C |
|
multiple interactions |
ISO |
15 |
50,923,105 |
50,926,047 |
RGD:6480464 |
CTD |
| G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
|
increases expression |
ISO |
1 |
23,501,257 |
23,506,651 |
RGD:6480464 |
CTD |
| G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
|
multiple interactions |
ISO |
1 |
23,501,257 |
23,506,651 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
multiple interactions |
ISO |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Slc25a36 |
solute carrier family 25 (pyrimidine nucleotide carrier ), member 36 |
|
multiple interactions |
ISO |
8 |
102,160,470 |
102,191,368 |
RGD:6480464 |
CTD |
| G |
Slc25a36l1 |
solute carrier family 25 (pyrimidine nucleotide carrier ), member 36-like 1 |
|
multiple interactions |
ISO |
19 |
34,878,831 |
34,879,927 |
RGD:6480464 |
CTD |
| G |
Slc39a8 |
solute carrier family 39 (zinc transporter), member 8 |
|
multiple interactions |
ISO |
2 |
233,340,397 |
233,403,461 |
RGD:6480464 |
CTD |
| G |
Slc6a14 |
solute carrier family 6 (amino acid transporter), member 14 |
|
multiple interactions |
ISO |
X |
12,048,993 |
12,072,434 |
RGD:6480464 |
CTD |
| G |
Slco4c1 |
solute carrier organic anion transporter family, member 4C1 |
|
multiple interactions |
ISO |
9 |
96,042,701 |
96,092,537 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
multiple interactions |
ISO |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
increases expression |
ISO |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
increases expression |
EXP |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb2 |
transforming growth factor, beta 2 |
|
multiple interactions |
ISO |
13 |
102,718,703 |
102,818,768 |
RGD:6480464 |
CTD |
| G |
Tgfb3 |
transforming growth factor, beta 3 |
|
multiple interactions |
ISO |
6 |
110,173,443 |
110,195,215 |
RGD:6480464 |
CTD |
| G |
Thra |
thyroid hormone receptor alpha |
|
multiple interactions |
ISO |
10 |
87,514,443 |
87,542,306 |
RGD:6480464 |
CTD |
| G |
Tmc5 |
transmembrane channel-like 5 |
|
multiple interactions |
ISO |
1 |
176,854,487 |
176,865,156 |
RGD:6480464 |
CTD |
| G |
Tnc |
tenascin C |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfsf4 |
tumor necrosis factor (ligand) superfamily, member 4 |
|
multiple interactions |
ISO |
13 |
77,026,337 |
77,050,223 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tpm1 |
tropomyosin 1, alpha |
|
multiple interactions |
ISO |
8 |
71,331,304 |
71,358,063 |
RGD:6480464 |
CTD |
| G |
Trim2 |
tripartite motif-containing 2 |
|
multiple interactions |
ISO |
2 |
175,908,880 |
175,974,709 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Wif1 |
Wnt inhibitory factor 1 |
|
multiple interactions |
ISO |
7 |
60,330,517 |
60,400,697 |
RGD:6480464 |
CTD |
| G |
Wnt5b |
wingless-type MMTV integration site family, member 5B |
|
multiple interactions |
ISO |
4 |
155,747,648 |
155,763,554 |
RGD:6480464 |
CTD |
8-bromo-3',5'-cyclic GMP
|
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
multiple interactions |
EXP |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Edn3 |
endothelin 3 |
|
multiple interactions |
EXP |
3 |
166,491,368 |
166,514,051 |
RGD:6480464 |
CTD |
| G |
Ednrb |
endothelin receptor type B |
|
multiple interactions |
EXP |
15 |
87,893,141 |
87,898,700 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
multiple interactions |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Il4 |
interleukin 4 |
|
increases expression |
ISO |
10 |
39,074,582 |
39,080,134 |
RGD:6480464 |
CTD |
| G |
Nfatc1 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
|
affects localization |
ISO |
18 |
77,498,654 |
77,581,231 |
RGD:6480464 |
CTD |
| G |
Pde5a |
phosphodiesterase 5A, cGMP-specific |
|
multiple interactions |
ISO |
2 |
219,410,394 |
219,550,910 |
RGD:6480464 |
CTD |
| G |
Prkg1 |
protein kinase, cGMP-dependent, type 1 |
|
increases expression |
EXP |
1 |
234,420,597 |
235,765,375 |
RGD:6480464 |
CTD |
| G |
Scnn1b |
sodium channel, nonvoltage-gated 1, beta |
|
multiple interactions |
ISO |
1 |
180,682,622 |
180,748,068 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
increases expression |
EXP |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
multiple interactions |
EXP |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
multiple interactions |
ISO |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
increases phosphorylation |
ISO |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Txn1 |
thioredoxin 1 |
|
multiple interactions |
EXP |
5 |
75,921,365 |
75,933,595 |
RGD:6480464 |
CTD |
benzbromarone
|
| G |
Abcb11 |
ATP-binding cassette, subfamily B (MDR/TAP), member 11 |
|
decreases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
affects activity |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
multiple interactions |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
affects activity |
ISO |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
decreases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc6 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 6 |
|
multiple interactions |
ISO |
1 |
96,448,588 |
96,524,655 |
RGD:6480464 |
CTD |
| G |
Abcc6 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 6 |
|
decreases activity |
ISO |
1 |
96,448,588 |
96,524,655 |
RGD:6480464 |
CTD |
| G |
Abcc6 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 6 |
|
affects expression |
EXP |
1 |
96,448,588 |
96,524,655 |
RGD:6480464 |
CTD |
| G |
Abcg5 |
ATP-binding cassette, subfamily G (WHITE), member 5 |
|
affects expression |
EXP |
6 |
8,027,647 |
8,064,425 |
RGD:6480464 |
CTD |
| G |
Abhd14b |
abhydrolase domain containing 14b |
|
affects expression |
EXP |
8 |
111,592,329 |
111,596,366 |
RGD:6480464 |
CTD |
| G |
Abhd17a |
abhydrolase domain containing 17A |
|
affects expression |
EXP |
7 |
10,635,489 |
10,641,920 |
RGD:6480464 |
CTD |
| G |
Acaca |
acetyl-CoA carboxylase alpha |
|
affects expression |
EXP |
10 |
72,483,772 |
72,677,134 |
RGD:6480464 |
CTD |
| G |
Acadl |
acyl-CoA dehydrogenase, long chain |
|
affects expression |
EXP |
9 |
65,613,130 |
65,651,775 |
RGD:6480464 |
CTD |
| G |
Aco1 |
aconitase 1, soluble |
|
affects expression |
EXP |
5 |
57,536,675 |
57,591,765 |
RGD:6480464 |
CTD |
| G |
Aco2 |
aconitase 2, mitochondrial |
|
affects expression |
EXP |
7 |
120,223,788 |
120,266,944 |
RGD:6480464 |
CTD |
| G |
Acot12 |
acyl-CoA thioesterase 12 |
|
affects expression |
EXP |
2 |
21,984,849 |
22,035,224 |
RGD:6480464 |
CTD |
| G |
Acot4 |
acyl-CoA thioesterase 4 |
|
affects expression |
EXP |
6 |
108,075,508 |
108,080,792 |
RGD:6480464 |
CTD |
| G |
Adam15 |
ADAM metallopeptidase domain 15 |
|
affects expression |
EXP |
2 |
181,527,175 |
181,537,640 |
RGD:6480464 |
CTD |
| G |
Add1 |
adducin 1 (alpha) |
|
affects expression |
EXP |
14 |
81,750,430 |
81,808,919 |
RGD:6480464 |
CTD |
| G |
Adh4 |
alcohol dehydrogenase 4 (class II), pi polypeptide |
|
affects expression |
EXP |
2 |
235,952,313 |
235,970,671 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
multiple interactions |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adtrp |
androgen-dependent TFPI-regulating protein |
|
affects expression |
EXP |
17 |
28,815,650 |
28,879,571 |
RGD:6480464 |
CTD |
| G |
Afm |
afamin |
|
affects expression |
EXP |
14 |
19,049,664 |
19,082,977 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
affects expression |
EXP |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agtr1a |
angiotensin II receptor, type 1a |
|
affects expression |
EXP |
17 |
40,629,318 |
40,684,982 |
RGD:6480464 |
CTD |
| G |
Akr1a1 |
aldo-keto reductase family 1, member A1 (aldehyde reductase) |
|
affects expression |
EXP |
5 |
136,920,561 |
136,937,422 |
RGD:6480464 |
CTD |
| G |
Akr1b8 |
aldo-keto reductase family 1, member B8 |
|
decreases activity |
EXP |
4 |
61,714,282 |
61,726,856 |
RGD:6480464 |
CTD |
| G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
|
decreases activity |
ISO |
17 |
77,084,306 |
77,112,994 |
RGD:6480464 |
CTD |
| G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
|
decreases activity |
ISO |
17 |
77,034,737 |
77,081,406 |
RGD:6480464 |
CTD |
| G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
|
decreases activity |
ISO |
17 |
77,269,626 |
77,286,521 |
RGD:6480464 |
CTD |
| G |
Akr7a2 |
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) |
|
affects expression |
EXP |
5 |
158,097,679 |
158,106,217 |
RGD:6480464 |
CTD |
| G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
affects expression |
EXP |
1 |
223,731,675 |
223,773,285 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
affects expression |
EXP |
12 |
36,081,778 |
36,116,445 |
RGD:6480464 |
CTD |
| G |
Alkbh7 |
alkB, alkylation repair homolog 7 (E. coli) |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ap2m1 |
adaptor-related protein complex 2, mu 1 subunit |
|
affects expression |
EXP |
11 |
82,585,474 |
82,591,832 |
RGD:6480464 |
CTD |
| G |
Apcs |
amyloid P component, serum |
|
affects expression |
EXP |
13 |
89,112,845 |
89,113,641 |
RGD:6480464 |
CTD |
| G |
Apoa4 |
apolipoprotein A-IV |
|
affects expression |
EXP |
8 |
49,233,142 |
49,233,431 |
RGD:6480464 |
CTD |
| G |
Apoh |
apolipoprotein H (beta-2-glycoprotein I) |
|
affects expression |
EXP |
10 |
97,725,088 |
97,739,213 |
RGD:6480464 |
CTD |
| G |
Apool |
apolipoprotein O-like |
|
affects expression |
EXP |
X |
100,911,059 |
100,979,133 |
RGD:6480464 |
CTD |
| G |
Arg1 |
arginase, liver |
|
affects expression |
EXP |
1 |
20,998,894 |
21,011,275 |
RGD:6480464 |
CTD |
| G |
Arl6ip1 |
ADP-ribosylation factor-like 6 interacting protein 1 |
|
affects expression |
EXP |
1 |
176,332,729 |
176,342,244 |
RGD:6480464 |
CTD |
| G |
Asgr2 |
asialoglycoprotein receptor 2 |
|
affects expression |
EXP |
10 |
56,942,683 |
56,955,742 |
RGD:6480464 |
CTD |
| G |
Atf5 |
activating transcription factor 5 |
|
affects expression |
EXP |
1 |
95,284,505 |
95,286,786 |
RGD:6480464 |
CTD |
| G |
Atp5e |
ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Atp5s |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit s (factor B) |
|
affects expression |
EXP |
6 |
91,771,989 |
91,799,619 |
RGD:6480464 |
CTD |
| G |
Atp6ap2 |
ATPase, H+ transporting, lysosomal accessory protein 2 |
|
affects expression |
EXP |
X |
22,264,078 |
22,291,988 |
RGD:6480464 |
CTD |
| G |
Atp6v1a |
ATPase, H+ transporting, lysosomal V1 subunit A |
|
affects expression |
EXP |
11 |
58,127,307 |
58,180,225 |
RGD:6480464 |
CTD |
| G |
Atp6v1f |
ATPase, H transporting, lysosomal V1 subunit F |
|
affects expression |
EXP |
4 |
56,347,184 |
56,350,085 |
RGD:6480464 |
CTD |
| G |
Baat |
bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase) |
|
affects expression |
EXP |
5 |
66,245,786 |
66,254,757 |
RGD:6480464 |
CTD |
| G |
Bcl6b |
B-cell CLL/lymphoma 6, member B |
|
affects expression |
EXP |
10 |
57,063,162 |
57,068,306 |
RGD:6480464 |
CTD |
| G |
Bmf |
Bcl2 modifying factor |
|
affects expression |
EXP |
3 |
104,966,652 |
104,984,752 |
RGD:6480464 |
CTD |
| G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
|
affects expression |
EXP |
1 |
198,683,009 |
198,700,075 |
RGD:6480464 |
CTD |
| G |
Btf3 |
basic transcription factor 3 |
|
affects expression |
EXP |
2 |
28,900,451 |
28,907,561 |
RGD:6480464 |
CTD |
| G |
C1qbp |
complement component 1, q subcomponent binding protein |
|
affects expression |
EXP |
10 |
57,881,783 |
57,886,434 |
RGD:6480464 |
CTD |
| G |
C1s |
complement component 1, s subcomponent |
|
affects expression |
EXP |
4 |
160,736,133 |
160,748,133 |
RGD:6480464 |
CTD |
| G |
C2cd2 |
C2 calcium-dependent domain containing 2 |
|
affects expression |
EXP |
11 |
37,873,369 |
37,935,054 |
RGD:6480464 |
CTD |
| G |
C4bpa |
complement component 4 binding protein, alpha |
|
affects expression |
EXP |
13 |
43,552,947 |
43,588,565 |
RGD:6480464 |
CTD |
| G |
C7 |
complement component 7 |
|
affects expression |
EXP |
2 |
54,147,136 |
54,250,803 |
RGD:6480464 |
CTD |
| G |
C8b |
complement component 8, beta polypeptide |
|
affects expression |
EXP |
5 |
125,728,606 |
125,766,093 |
RGD:6480464 |
CTD |
| G |
Ca2 |
carbonic anhydrase 2 |
|
affects expression |
EXP |
2 |
88,077,095 |
88,092,223 |
RGD:6480464 |
CTD |
| G |
Cadps2 |
Ca++-dependent secretion activator 2 |
|
affects expression |
EXP |
4 |
49,658,535 |
50,206,014 |
RGD:6480464 |
CTD |
| G |
Caprin1 |
cell cycle associated protein 1 |
|
affects expression |
EXP |
3 |
89,062,097 |
89,093,093 |
RGD:6480464 |
CTD |
| G |
Car3 |
carbonic anhydrase 3 |
|
affects expression |
EXP |
2 |
88,106,727 |
88,114,686 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
affects expression |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cbr1 |
carbonyl reductase 1 |
|
affects expression |
EXP |
11 |
33,787,957 |
33,790,320 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
increases expression |
ISO |
4 |
13,471,878 |
13,525,620 |
RGD:6480464 |
CTD |
| G |
Cdo1 |
cysteine dioxygenase, type I |
|
affects expression |
EXP |
18 |
40,914,028 |
40,928,671 |
RGD:6480464 |
CTD |
| G |
Cept1 |
choline/ethanolamine phosphotransferase 1 |
|
affects expression |
EXP |
2 |
201,801,921 |
201,843,259 |
RGD:6480464 |
CTD |
| G |
Ces2h |
carboxylesterase 2H |
|
affects expression |
EXP |
19 |
34,910,981 |
34,925,547 |
RGD:6480464 |
CTD |
| G |
Cfi |
complement factor I |
|
affects expression |
EXP |
2 |
227,281,621 |
227,325,109 |
RGD:6480464 |
CTD |
| G |
Chp |
calcium binding protein p22 |
|
affects expression |
EXP |
3 |
106,066,389 |
106,101,635 |
RGD:6480464 |
CTD |
| G |
Cisd1 |
CDGSH iron sulfur domain 1 |
|
affects expression |
EXP |
20 |
17,985,985 |
17,999,366 |
RGD:6480464 |
CTD |
| G |
Clcn4 |
chloride channel, voltage-sensitive 4 |
|
affects expression |
EXP |
X |
44,355,648 |
44,419,524 |
RGD:6480464 |
CTD |
| G |
Clpp |
ClpP caseinolytic peptidase, ATP-dependent, proteolytic subunit homolog (E. coli) |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Clptm1l |
CLPTM1-like |
|
affects expression |
EXP |
1 |
30,474,672 |
30,490,655 |
RGD:6480464 |
CTD |
| G |
Cmbl |
carboxymethylenebutenolidase homolog (Pseudomonas) |
|
affects expression |
EXP |
2 |
83,659,292 |
83,681,042 |
RGD:6480464 |
CTD |
| G |
Cmpk1 |
cytidine monophosphate (UMP-CMP) kinase 1 |
|
affects expression |
EXP |
5 |
135,320,845 |
135,348,973 |
RGD:6480464 |
CTD |
| G |
Copg1 |
coatomer protein complex, subunit gamma 1 |
|
affects expression |
EXP |
4 |
122,109,613 |
122,134,049 |
RGD:6480464 |
CTD |
| G |
Cops4 |
COP9 signalosome subunit 4 |
|
affects expression |
EXP |
14 |
10,329,870 |
10,360,081 |
RGD:6480464 |
CTD |
| G |
Coq3 |
coenzyme Q3 homolog, methyltransferase (S. cerevisiae) |
|
affects expression |
EXP |
5 |
36,640,718 |
36,656,981 |
RGD:6480464 |
CTD |
| G |
Cox4i1 |
cytochrome c oxidase subunit IV isoform 1 |
|
affects expression |
EXP |
19 |
51,023,960 |
51,030,200 |
RGD:6480464 |
CTD |
| G |
Cpn1 |
carboxypeptidase N, polypeptide 1 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cpq |
carboxypeptidase Q |
|
affects expression |
EXP |
7 |
68,430,069 |
68,900,500 |
RGD:6480464 |
CTD |
| G |
Crem |
cAMP responsive element modulator |
|
affects expression |
EXP |
17 |
62,770,633 |
62,837,670 |
RGD:6480464 |
CTD |
| G |
Crp |
C-reactive protein, pentraxin-related |
|
multiple interactions |
ISO |
13 |
88,702,243 |
88,703,153 |
RGD:6480464 |
CTD |
| G |
Crp |
C-reactive protein, pentraxin-related |
|
decreases expression |
ISO |
13 |
88,702,243 |
88,703,153 |
RGD:6480464 |
CTD |
| G |
Csnk2b |
casein kinase 2, beta polypeptide |
|
affects expression |
EXP |
20 |
3,764,565 |
3,768,985 |
RGD:6480464 |
CTD |
| G |
Csrp1 |
cysteine and glycine-rich protein 1 |
|
affects expression |
EXP |
13 |
48,750,202 |
48,775,815 |
RGD:6480464 |
CTD |
| G |
Ctnna1 |
catenin (cadherin-associated protein), alpha 1, 102kDa |
|
affects expression |
EXP |
18 |
27,629,915 |
27,769,360 |
RGD:6480464 |
CTD |
| G |
Cyp2a1 |
cytochrome P450, family 2, subfamily a, polypeptide 1 |
|
affects expression |
EXP |
1 |
82,006,828 |
82,020,282 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
affects expression |
EXP |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
multiple interactions |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
affects metabolic processing |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
multiple interactions |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
multiple interactions |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
affects binding |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
multiple interactions |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
multiple interactions |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
multiple interactions |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
affects metabolic processing |
ISO |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2d3 |
cytochrome P450, family 2, subfamily d, polypeptide 3 |
|
affects expression |
EXP |
7 |
120,778,783 |
120,783,140 |
RGD:6480464 |
CTD |
| G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
affects expression |
EXP |
7 |
120,742,273 |
120,752,274 |
RGD:6480464 |
CTD |
| G |
Cyp2f4 |
cytochrome P450, family 2, subfamily f, polypeptide 4 |
|
affects expression |
EXP |
1 |
82,191,741 |
82,204,629 |
RGD:6480464 |
CTD |
| G |
Cyp2j4 |
cytochrome P450, family 2, subfamily j, polypeptide 4 |
|
affects expression |
EXP |
5 |
116,702,370 |
116,729,722 |
RGD:6480464 |
CTD |
| G |
Cyp2t1 |
cytochrome P450, family 2, subfamily t, polypeptide 1 |
|
affects expression |
EXP |
1 |
82,229,581 |
82,233,249 |
RGD:6480464 |
CTD |
| G |
Cyp3a23/3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23/polypeptide 1 |
|
affects expression |
EXP |
12 |
9,567,120 |
9,595,974 |
RGD:6480464 |
CTD |
| G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
|
affects expression |
EXP |
12 |
17,164,384 |
17,204,589 |
RGD:6480464 |
CTD |
| G |
Cyp4a8 |
cytochrome P450, family 4, subfamily a, polypeptide 8 |
|
affects expression |
EXP |
5 |
135,546,858 |
135,578,199 |
RGD:6480464 |
CTD |
| G |
Cyp4f6 |
cytochrome P450, family 4, subfamily f, polypeptide 6 |
|
affects expression |
EXP |
7 |
13,609,104 |
13,636,290 |
RGD:6480464 |
CTD |
| G |
Dak |
dihydroxyacetone kinase 2 homolog (S. cerevisiae) |
|
affects expression |
EXP |
1 |
213,081,825 |
213,095,034 |
RGD:6480464 |
CTD |
| G |
Dbi |
diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein) |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Dcaf11 |
DDB1 and CUL4 associated factor 11 |
|
affects expression |
EXP |
15 |
33,691,576 |
33,701,328 |
RGD:6480464 |
CTD |
| G |
Dcxr |
dicarbonyl L-xylulose reductase |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Decr1 |
2,4-dienoyl CoA reductase 1, mitochondrial |
|
affects expression |
EXP |
5 |
30,492,196 |
30,520,172 |
RGD:6480464 |
CTD |
| G |
Dexi |
dexamethasone-induced transcript |
|
affects expression |
EXP |
10 |
5,072,036 |
5,084,723 |
RGD:6480464 |
CTD |
| G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
|
affects expression |
EXP |
7 |
114,552,051 |
114,562,423 |
RGD:6480464 |
CTD |
| G |
Dhcr24 |
24-dehydrocholesterol reductase |
|
affects expression |
EXP |
5 |
127,637,438 |
127,662,621 |
RGD:6480464 |
CTD |
| G |
Dhrs4 |
dehydrogenase/reductase (SDR family) member 4 |
|
affects expression |
EXP |
15 |
33,609,570 |
33,621,142 |
RGD:6480464 |
CTD |
| G |
Dhrs7b |
dehydrogenase/reductase (SDR family) member 7B |
|
affects expression |
EXP |
10 |
46,971,430 |
47,003,953 |
RGD:6480464 |
CTD |
| G |
Dhx16 |
DEAH (Asp-Glu-Ala-His) box polypeptide 16 |
|
affects expression |
EXP |
20 |
3,009,770 |
3,022,969 |
RGD:6480464 |
CTD |
| G |
Dnajc3 |
DnaJ (Hsp40) homolog, subfamily C, member 3 |
|
affects expression |
EXP |
15 |
103,881,634 |
103,921,295 |
RGD:6480464 |
CTD |
| G |
Dpp4 |
dipeptidylpeptidase 4 |
|
affects expression |
EXP |
3 |
44,279,255 |
44,360,283 |
RGD:6480464 |
CTD |
| G |
Dpyd |
dihydropyrimidine dehydrogenase |
|
affects expression |
EXP |
2 |
214,931,901 |
215,818,809 |
RGD:6480464 |
CTD |
| G |
Ears2 |
glutamyl-tRNA synthetase 2, mitochondrial |
|
affects expression |
EXP |
1 |
180,861,635 |
180,889,473 |
RGD:6480464 |
CTD |
| G |
Echs1 |
enoyl CoA hydratase, short chain, 1, mitochondrial |
|
affects expression |
EXP |
1 |
199,901,585 |
199,910,412 |
RGD:6480464 |
CTD |
| G |
Eci1 |
enoyl-CoA delta isomerase 1 |
|
affects expression |
EXP |
10 |
13,683,000 |
13,697,179 |
RGD:6480464 |
CTD |
| G |
Eci2 |
enoyl-CoA delta isomerase 2 |
|
affects expression |
EXP |
17 |
36,198,752 |
36,215,199 |
RGD:6480464 |
CTD |
| G |
Eef1g |
eukaryotic translation elongation factor 1 gamma |
|
affects expression |
EXP |
1 |
211,640,954 |
211,651,560 |
RGD:6480464 |
CTD |
| G |
Ehhadh |
enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase |
|
affects expression |
EXP |
11 |
81,474,161 |
81,507,645 |
RGD:6480464 |
CTD |
| G |
Eif4a2 |
eukaryotic translation initiation factor 4A2 |
|
affects expression |
EXP |
11 |
79,950,592 |
79,957,185 |
RGD:6480464 |
CTD |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
affects expression |
EXP |
16 |
69,110,522 |
69,123,895 |
RGD:6480464 |
CTD |
| G |
Eif4h |
eukaryotic translation initiation factor 4H |
|
affects expression |
EXP |
12 |
23,148,332 |
23,164,980 |
RGD:6480464 |
CTD |
| G |
Enc1 |
ectodermal-neural cortex 1 |
|
affects expression |
EXP |
2 |
27,720,805 |
27,733,168 |
RGD:6480464 |
CTD |
| G |
Eno1 |
enolase 1, (alpha) |
|
affects expression |
EXP |
5 |
167,394,131 |
167,405,516 |
RGD:6480464 |
CTD |
| G |
Enpep |
glutamyl aminopeptidase |
|
affects expression |
EXP |
2 |
226,731,079 |
226,732,069 |
RGD:6480464 |
CTD |
| G |
Enpp1 |
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
|
affects expression |
EXP |
1 |
21,223,678 |
21,287,411 |
RGD:6480464 |
CTD |
| G |
Epcam |
epithelial cell adhesion molecule |
|
affects expression |
EXP |
6 |
11,176,664 |
11,192,628 |
RGD:6480464 |
CTD |
| G |
Erp29 |
endoplasmic reticulum protein 29 |
|
affects expression |
EXP |
12 |
36,225,110 |
36,231,363 |
RGD:6480464 |
CTD |
| G |
Esd |
esterase D |
|
affects expression |
EXP |
15 |
55,556,681 |
55,576,172 |
RGD:6480464 |
CTD |
| G |
Etfb |
electron-transfer-flavoprotein, beta polypeptide |
|
affects expression |
EXP |
1 |
93,820,124 |
93,834,288 |
RGD:6480464 |
CTD |
| G |
Eya2 |
eyes absent homolog 2 (Drosophila) |
|
decreases activity |
ISO |
3 |
156,731,490 |
156,848,691 |
RGD:6480464 |
CTD |
| G |
Eya3 |
eyes absent homolog 3 (Drosophila) |
|
decreases activity |
ISO |
5 |
152,427,552 |
152,507,813 |
RGD:6480464 |
CTD |
| G |
Faah |
fatty acid amide hydrolase |
|
affects expression |
EXP |
5 |
136,310,965 |
136,329,817 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
increases expression |
ISO |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fads2 |
fatty acid desaturase 2 |
|
affects expression |
EXP |
1 |
212,512,691 |
212,542,622 |
RGD:6480464 |
CTD |
| G |
Fbp1 |
fructose-1,6-bisphosphatase 1 |
|
affects expression |
EXP |
17 |
7,795,717 |
7,818,041 |
RGD:6480464 |
CTD |
| G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
|
affects expression |
EXP |
15 |
42,425,336 |
42,453,390 |
RGD:6480464 |
CTD |
| G |
Fdps |
farnesyl diphosphate synthase |
|
affects expression |
EXP |
2 |
181,138,474 |
181,177,903 |
RGD:6480464 |
CTD |
| G |
Fdx1l |
ferredoxin 1-like |
|
affects expression |
EXP |
8 |
20,091,424 |
20,096,340 |
RGD:6480464 |
CTD |
| G |
Fmo1 |
flavin containing monooxygenase 1 |
|
affects expression |
EXP |
13 |
78,503,770 |
78,536,359 |
RGD:6480464 |
CTD |
| G |
Gamt |
guanidinoacetate N-methyltransferase |
|
affects expression |
EXP |
7 |
10,959,990 |
10,962,720 |
RGD:6480464 |
CTD |
| G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
affects expression |
EXP |
4 |
161,282,215 |
161,286,090 |
RGD:6480464 |
CTD |
| G |
Gbe1 |
glucan (1,4-alpha-), branching enzyme 1 |
|
affects expression |
EXP |
11 |
8,720,408 |
8,975,471 |
RGD:6480464 |
CTD |
| G |
Gchfr |
GTP cyclohydrolase I feedback regulator |
|
affects expression |
EXP |
3 |
105,683,288 |
105,687,349 |
RGD:6480464 |
CTD |
| G |
Ggh |
gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase) |
|
affects expression |
EXP |
5 |
34,670,883 |
34,693,791 |
RGD:6480464 |
CTD |
| G |
Gjb1 |
gap junction protein, beta 1 |
|
affects expression |
EXP |
X |
89,448,873 |
89,456,812 |
RGD:6480464 |
CTD |
| G |
Gpld1 |
glycosylphosphatidylinositol specific phospholipase D1 |
|
affects expression |
EXP |
17 |
47,145,567 |
47,188,345 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx4 |
glutathione peroxidase 4 |
|
affects expression |
EXP |
7 |
11,162,521 |
11,165,318 |
RGD:6480464 |
CTD |
| G |
Grina |
glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding) |
|
affects expression |
EXP |
7 |
114,277,208 |
114,280,339 |
RGD:6480464 |
CTD |
| G |
Grpel1 |
GrpE-like 1, mitochondrial |
|
affects expression |
EXP |
14 |
79,873,191 |
79,878,998 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
affects expression |
EXP |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gtf2h5 |
general transcription factor IIH, polypeptide 5 |
|
affects expression |
EXP |
1 |
40,858,997 |
40,865,571 |
RGD:6480464 |
CTD |
| G |
Gulo |
gulonolactone (L-) oxidase |
|
affects expression |
EXP |
15 |
45,410,685 |
45,434,014 |
RGD:6480464 |
CTD |
| G |
Gzma |
granzyme A |
|
affects expression |
EXP |
2 |
44,488,295 |
44,500,128 |
RGD:6480464 |
CTD |
| G |
H3f3b |
H3 histone, family 3B |
|
affects expression |
EXP |
10 |
106,130,320 |
106,132,544 |
RGD:6480464 |
CTD |
| G |
Hal |
histidine ammonia lyase |
|
affects expression |
EXP |
7 |
30,520,913 |
30,551,145 |
RGD:6480464 |
CTD |
| G |
Hao2 |
hydroxyacid oxidase 2 (long chain) |
|
affects expression |
EXP |
2 |
193,532,833 |
193,557,229 |
RGD:6480464 |
CTD |
| G |
Hba1 |
hemoglobin, alpha 1 |
|
affects expression |
EXP |
10 |
15,584,360 |
15,585,215 |
RGD:6480464 |
CTD |
| G |
Hbb |
hemoglobin, beta |
|
affects expression |
EXP |
1 |
161,618,782 |
161,620,193 |
RGD:6480464 |
CTD |
| G |
Hdc |
histidine decarboxylase |
|
affects expression |
EXP |
3 |
114,119,316 |
114,138,107 |
RGD:6480464 |
CTD |
| G |
Hgd |
homogentisate 1, 2-dioxygenase |
|
affects expression |
EXP |
11 |
64,876,269 |
64,928,243 |
RGD:6480464 |
CTD |
| G |
Hmgn1 |
high mobility group nucleosome binding domain 1 |
|
affects expression |
EXP |
11 |
36,429,800 |
36,435,719 |
RGD:6480464 |
CTD |
| G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
|
affects expression |
EXP |
X |
139,929,647 |
139,961,616 |
RGD:6480464 |
CTD |
| G |
Hps5 |
Hermansky-Pudlak syndrome 5 |
|
affects expression |
EXP |
1 |
97,312,474 |
97,351,792 |
RGD:6480464 |
CTD |
| G |
Hrsp12 |
heat-responsive protein 12 |
|
affects expression |
EXP |
7 |
69,930,464 |
69,944,267 |
RGD:6480464 |
CTD |
| G |
Hsd17b4 |
hydroxysteroid (17-beta) dehydrogenase 4 |
|
affects expression |
EXP |
18 |
45,157,435 |
45,251,606 |
RGD:6480464 |
CTD |
| G |
Hsdl2 |
hydroxysteroid dehydrogenase like 2 |
|
affects expression |
EXP |
5 |
77,680,173 |
77,716,789 |
RGD:6480464 |
CTD |
| G |
Htra1 |
HtrA serine peptidase 1 |
|
affects expression |
EXP |
1 |
190,257,899 |
190,308,325 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
affects expression |
EXP |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igfals |
insulin-like growth factor binding protein, acid labile subunit |
|
affects expression |
EXP |
10 |
14,127,416 |
14,130,662 |
RGD:6480464 |
CTD |
| G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
|
affects expression |
EXP |
9 |
71,966,877 |
71,994,211 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
multiple interactions |
ISO |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Impa1 |
Inositol (myo)-1(or 4)-monophosphatase 1 |
|
affects expression |
EXP |
2 |
93,415,958 |
93,438,247 |
RGD:6480464 |
CTD |
| G |
Inhbe |
inhibin beta E |
|
affects expression |
EXP |
7 |
67,308,713 |
67,310,138 |
RGD:6480464 |
CTD |
| G |
Isyna1 |
inositol-3-phosphate synthase 1 |
|
affects expression |
EXP |
16 |
19,345,305 |
19,348,141 |
RGD:6480464 |
CTD |
| G |
Itih4 |
inter-alpha-trypsin inhibitor heavy chain family, member 4 |
|
affects expression |
EXP |
16 |
6,319,608 |
6,334,782 |
RGD:6480464 |
CTD |
| G |
Jak1 |
Janus kinase 1 |
|
affects expression |
EXP |
5 |
121,804,586 |
121,905,581 |
RGD:6480464 |
CTD |
| G |
Kdelr2 |
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Kdr |
kinase insert domain receptor |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Krt8 |
keratin 8 |
|
affects expression |
EXP |
7 |
140,713,902 |
140,721,199 |
RGD:6480464 |
CTD |
| G |
Lcat |
lecithin cholesterol acyltransferase |
|
affects expression |
EXP |
19 |
35,781,507 |
35,784,966 |
RGD:6480464 |
CTD |
| G |
Lcmt1 |
leucine carboxyl methyltransferase 1 |
|
affects expression |
EXP |
1 |
182,242,293 |
182,298,243 |
RGD:6480464 |
CTD |
| G |
Lipc |
lipase, hepatic |
|
affects expression |
EXP |
8 |
75,323,442 |
75,450,353 |
RGD:6480464 |
CTD |
| G |
LOC100360920 |
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 |
|
affects expression |
EXP |
12 |
11,498,420 |
11,513,595 |
RGD:6480464 |
CTD |
| G |
LOC100361295 |
methylmalonyl-Coenzyme A mutase |
|
affects expression |
EXP |
9 |
15,768,911 |
15,797,489 |
RGD:6480464 |
CTD |
| G |
LOC100363268 |
rCG31129-like |
|
affects expression |
EXP |
2 |
189,674,857 |
189,675,177 |
RGD:6480464 |
CTD |
| G |
Lox |
lysyl oxidase |
|
affects expression |
EXP |
18 |
47,896,674 |
47,970,829 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
increases expression |
ISO |
16 |
22,533,105 |
22,556,905 |
RGD:6480464 |
CTD |
| G |
Lrp3 |
low density lipoprotein receptor-related protein 3 |
|
affects expression |
EXP |
1 |
87,711,390 |
87,725,636 |
RGD:6480464 |
CTD |
| G |
Lsmd1 |
LSM domain containing 1 |
|
affects expression |
EXP |
10 |
56,190,119 |
56,191,724 |
RGD:6480464 |
CTD |
| G |
Man2b1 |
mannosidase, alpha, class 2B, member 1 |
|
affects expression |
EXP |
19 |
24,711,378 |
24,730,659 |
RGD:6480464 |
CTD |
| G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
|
affects expression |
EXP |
7 |
10,074,654 |
10,094,003 |
RGD:6480464 |
CTD |
| G |
Masp2 |
mannan-binding lectin serine peptidase 2 |
|
affects expression |
EXP |
5 |
165,682,509 |
165,696,426 |
RGD:6480464 |
CTD |
| G |
Me1 |
malic enzyme 1, NADP(+)-dependent, cytosolic |
|
affects expression |
EXP |
8 |
91,839,845 |
91,955,917 |
RGD:6480464 |
CTD |
| G |
Mro |
maestro |
|
affects expression |
EXP |
18 |
70,648,892 |
70,660,961 |
RGD:6480464 |
CTD |
| G |
Mrpl2 |
mitochondrial ribosomal protein L2 |
|
affects expression |
EXP |
9 |
10,016,260 |
10,020,033 |
RGD:6480464 |
CTD |
| G |
mrpl9 |
mitochondrial ribosomal protein L9 |
|
affects expression |
EXP |
2 |
189,417,391 |
189,422,111 |
RGD:6480464 |
CTD |
| G |
Mut |
methylmalonyl CoA mutase |
|
affects expression |
EXP |
9 |
16,065,495 |
16,093,956 |
RGD:6480464 |
CTD |
| G |
Myadm |
myeloid-associated differentiation marker |
|
affects expression |
EXP |
1 |
64,177,547 |
64,185,893 |
RGD:6480464 |
CTD |
| G |
Mycbp2 |
MYC binding protein 2, E3 ubiquitin protein ligase |
|
affects expression |
EXP |
15 |
87,124,558 |
87,364,839 |
RGD:6480464 |
CTD |
| G |
Myo1d |
myosin ID |
|
affects expression |
EXP |
10 |
68,720,729 |
68,997,721 |
RGD:6480464 |
CTD |
| G |
Nap1l1 |
nucleosome assembly protein 1-like 1 |
|
affects expression |
EXP |
7 |
50,506,870 |
50,530,177 |
RGD:6480464 |
CTD |
| G |
Nat8 |
N-acetyltransferase 8 |
|
affects expression |
EXP |
4 |
120,001,277 |
120,002,055 |
RGD:6480464 |
CTD |
| G |
Ndrg2 |
NDRG family member 2 |
|
affects expression |
EXP |
15 |
27,338,552 |
27,347,196 |
RGD:6480464 |
CTD |
| G |
Ndufs5 |
NADH dehydrogenase (ubiquinone) Fe-S protein 5 |
|
affects expression |
EXP |
5 |
143,017,421 |
143,023,425 |
RGD:6480464 |
CTD |
| G |
Ndufv3 |
NADH dehydrogenase (ubiquinone) flavoprotein 3 |
|
affects expression |
EXP |
20 |
9,951,109 |
9,960,265 |
RGD:6480464 |
CTD |
| G |
Neu2 |
sialidase 2 |
|
affects expression |
EXP |
9 |
86,553,196 |
86,556,412 |
RGD:6480464 |
CTD |
| G |
Nfx1 |
nuclear transcription factor, X-box binding 1 |
|
affects expression |
EXP |
5 |
58,366,449 |
58,424,124 |
RGD:6480464 |
CTD |
| G |
Nit1 |
nitrilase 1 |
|
affects expression |
EXP |
13 |
87,242,619 |
87,246,055 |
RGD:6480464 |
CTD |
| G |
Nme2 |
NME/NM23 nucleoside diphosphate kinase 2 |
|
affects expression |
EXP |
10 |
82,582,766 |
82,588,269 |
RGD:6480464 |
CTD |
| G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
|
affects expression |
EXP |
13 |
87,104,241 |
87,108,563 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
affects expression |
EXP |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Oaf |
OAF homolog (Drosophila) |
|
affects expression |
EXP |
8 |
46,224,861 |
46,242,832 |
RGD:6480464 |
CTD |
| G |
Obp3 |
alpha-2u globulin PGCL4 |
|
affects expression |
EXP |
5 |
78,088,876 |
78,092,317 |
RGD:6480464 |
CTD |
| G |
Ogdh |
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) |
|
affects expression |
EXP |
14 |
87,022,994 |
87,090,768 |
RGD:6480464 |
CTD |
| G |
Olr59 |
olfactory receptor 59 |
|
affects expression |
EXP |
1 |
160,607,895 |
160,613,826 |
RGD:6480464 |
CTD |
| G |
Ostc |
oligosaccharyltransferase complex subunit (non-catalytic) |
|
affects expression |
EXP |
2 |
228,112,093 |
228,127,992 |
RGD:6480464 |
CTD |
| G |
Otc |
ornithine carbamoyltransferase |
|
affects expression |
EXP |
X |
24,609,141 |
24,685,341 |
RGD:6480464 |
CTD |
| G |
Pabpc4 |
poly(A) binding protein, cytoplasmic 4 |
|
affects expression |
EXP |
5 |
142,599,706 |
142,615,003 |
RGD:6480464 |
CTD |
| G |
Paics |
phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase |
|
affects expression |
EXP |
14 |
33,492,707 |
33,509,389 |
RGD:6480464 |
CTD |
| G |
Pc |
pyruvate carboxylase |
|
affects expression |
EXP |
1 |
207,112,853 |
207,212,737 |
RGD:6480464 |
CTD |
| G |
Pccb |
propionyl CoA carboxylase, beta polypeptide |
|
affects expression |
EXP |
8 |
105,946,482 |
105,996,472 |
RGD:6480464 |
CTD |
| G |
Pcsk6 |
proprotein convertase subtilisin/kexin type 6 |
|
affects expression |
EXP |
1 |
120,324,843 |
120,476,913 |
RGD:6480464 |
CTD |
| G |
Pctp |
phosphatidylcholine transfer protein |
|
affects expression |
EXP |
10 |
78,400,328 |
78,420,774 |
RGD:6480464 |
CTD |
| G |
Pdcl3 |
phosducin-like 3 |
|
affects expression |
EXP |
9 |
38,004,222 |
38,012,693 |
RGD:6480464 |
CTD |
| G |
Pdia3 |
protein disulfide isomerase family A, member 3 |
|
affects expression |
EXP |
3 |
108,216,414 |
108,240,138 |
RGD:6480464 |
CTD |
| G |
Pdia6 |
protein disulfide isomerase family A, member 6 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Pex19 |
peroxisomal biogenesis factor 19 |
|
affects expression |
EXP |
13 |
88,122,462 |
88,139,003 |
RGD:6480464 |
CTD |
| G |
Pgam1 |
phosphoglycerate mutase 1 (brain) |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Pgrmc1 |
progesterone receptor membrane component 1 |
|
affects expression |
EXP |
X |
8,265,543 |
8,273,667 |
RGD:6480464 |
CTD |
| G |
Phyh |
phytanoyl-CoA 2-hydroxylase |
|
affects expression |
EXP |
17 |
84,418,173 |
84,435,073 |
RGD:6480464 |
CTD |
| G |
Pigp |
phosphatidylinositol glycan anchor biosynthesis, class P |
|
affects expression |
EXP |
11 |
34,610,876 |
34,617,001 |
RGD:6480464 |
CTD |
| G |
Pklr |
pyruvate kinase, liver and RBC |
|
affects expression |
EXP |
2 |
181,214,853 |
181,223,505 |
RGD:6480464 |
CTD |
| G |
Plbd1 |
phospholipase B domain containing 1 |
|
affects expression |
EXP |
4 |
173,611,465 |
173,667,759 |
RGD:6480464 |
CTD |
| G |
Plg |
plasminogen |
|
affects expression |
EXP |
1 |
42,782,464 |
42,825,149 |
RGD:6480464 |
CTD |
| G |
Pls3 |
plastin 3 |
|
affects expression |
EXP |
X |
29,868,937 |
29,965,118 |
RGD:6480464 |
CTD |
| G |
Pon2 |
paraoxonase 2 |
|
affects expression |
EXP |
4 |
30,033,229 |
30,068,643 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
affects expression |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Ppdpf |
pancreatic progenitor cell differentiation and proliferation factor homolog (zebrafish) |
|
affects expression |
EXP |
3 |
170,329,529 |
170,330,471 |
RGD:6480464 |
CTD |
| G |
Pqlc1 |
PQ loop repeat containing 1 |
|
affects expression |
EXP |
18 |
77,151,194 |
77,187,603 |
RGD:6480464 |
CTD |
| G |
Prdx2 |
peroxiredoxin 2 |
|
affects expression |
EXP |
19 |
24,836,199 |
24,841,390 |
RGD:6480464 |
CTD |
| G |
Prdx6 |
peroxiredoxin 6 |
|
affects expression |
EXP |
13 |
76,824,968 |
76,835,517 |
RGD:6480464 |
CTD |
| G |
Proc |
protein C |
|
affects expression |
EXP |
18 |
24,563,368 |
24,573,715 |
RGD:6480464 |
CTD |
| G |
Prpsap1 |
phosphoribosyl pyrophosphate synthetase-associated protein 1 |
|
affects expression |
EXP |
10 |
106,582,381 |
106,604,072 |
RGD:6480464 |
CTD |
| G |
Psma6 |
proteasome (prosome, macropain) subunit, alpha type 6 |
|
affects expression |
EXP |
6 |
75,649,844 |
75,667,404 |
RGD:6480464 |
CTD |
| G |
Psmb1 |
proteasome (prosome, macropain) subunit, beta type 1 |
|
affects expression |
EXP |
1 |
54,369,775 |
54,388,816 |
RGD:6480464 |
CTD |
| G |
Psmb3 |
proteasome (prosome, macropain) subunit, beta type 3 |
|
affects expression |
EXP |
10 |
86,452,533 |
86,459,616 |
RGD:6480464 |
CTD |
| G |
Psmc1 |
proteasome (prosome, macropain) 26S subunit, ATPase, 1 |
|
affects expression |
EXP |
6 |
124,380,976 |
124,393,338 |
RGD:6480464 |
CTD |
| G |
Psmc3 |
proteasome (prosome, macropain) 26S subunit, ATPase 3 |
|
affects expression |
EXP |
3 |
75,413,567 |
75,418,948 |
RGD:6480464 |
CTD |
| G |
Psmc5 |
proteasome (prosome, macropain) 26S subunit, ATPase, 5 |
|
affects expression |
EXP |
10 |
95,650,987 |
95,656,921 |
RGD:6480464 |
CTD |
| G |
Psmd1 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 1 |
|
affects expression |
EXP |
9 |
84,807,822 |
84,882,942 |
RGD:6480464 |
CTD |
| G |
Psmd4 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 4 |
|
affects expression |
EXP |
2 |
189,933,161 |
189,942,421 |
RGD:6480464 |
CTD |
| G |
Ptms |
parathymosin |
|
affects expression |
EXP |
4 |
161,041,242 |
161,045,145 |
RGD:6480464 |
CTD |
| G |
Ptprf |
protein tyrosine phosphatase, receptor type, F |
|
affects expression |
EXP |
5 |
138,671,725 |
138,739,002 |
RGD:6480464 |
CTD |
| G |
Pttg1ip |
pituitary tumor-transforming 1 interacting protein |
|
affects expression |
EXP |
20 |
11,414,678 |
11,431,939 |
RGD:6480464 |
CTD |
| G |
Pygl |
phosphorylase, glycogen, liver |
|
affects expression |
EXP |
6 |
92,298,339 |
92,341,347 |
RGD:6480464 |
CTD |
| G |
Pzp |
pregnancy-zone protein |
|
affects expression |
EXP |
4 |
165,505,104 |
165,579,027 |
RGD:6480464 |
CTD |
| G |
RGD1307752 |
similar to RIKEN cDNA 1110008F13 |
|
affects expression |
EXP |
3 |
147,266,788 |
147,276,798 |
RGD:6480464 |
CTD |
| G |
Rnase4 |
ribonuclease, RNase A family 4 |
|
affects expression |
EXP |
15 |
27,073,756 |
27,090,441 |
RGD:6480464 |
CTD |
| G |
Rnf103 |
ring finger protein 103 |
|
affects expression |
EXP |
4 |
104,762,184 |
104,778,157 |
RGD:6480464 |
CTD |
| G |
Rnps1 |
ribonucleic acid binding protein S1 |
|
affects expression |
EXP |
10 |
13,670,753 |
13,681,591 |
RGD:6480464 |
CTD |
| G |
Rpl11 |
ribosomal protein L11 |
|
affects expression |
EXP |
5 |
154,826,973 |
154,830,183 |
RGD:6480464 |
CTD |
| G |
Rpl13 |
ribosomal protein L13 |
|
affects expression |
EXP |
19 |
53,437,633 |
53,440,184 |
RGD:6480464 |
CTD |
| G |
Rpl15 |
ribosomal protein L15 |
|
affects expression |
EXP |
15 |
9,082,190 |
9,085,473 |
RGD:6480464 |
CTD |
| G |
Rpl17 |
ribosomal protein L17 |
|
affects expression |
EXP |
18 |
71,863,062 |
71,866,168 |
RGD:6480464 |
CTD |
| G |
Rpl17l1 |
ribosomal protein L17-like 1 |
|
affects expression |
EXP |
1 |
64,205,419 |
64,205,973 |
RGD:6480464 |
CTD |
| G |
Rpl23 |
ribosomal protein L23 |
|
affects expression |
EXP |
10 |
86,527,589 |
86,531,549 |
RGD:6480464 |
CTD |
| G |
Rpl3 |
ribosomal protein L3 |
|
affects expression |
EXP |
7 |
118,314,537 |
118,319,911 |
RGD:6480464 |
CTD |
| G |
Rpl32 |
ribosomal protein L32 |
|
affects expression |
EXP |
4 |
151,941,599 |
151,945,012 |
RGD:6480464 |
CTD |
| G |
Rpl4 |
ribosomal protein L4 |
|
affects expression |
EXP |
8 |
68,366,802 |
68,371,925 |
RGD:6480464 |
CTD |
| G |
Rpn2 |
ribophorin II |
|
affects expression |
EXP |
3 |
147,976,544 |
148,023,743 |
RGD:6480464 |
CTD |
| G |
Rps14 |
ribosomal protein S14 |
|
affects expression |
EXP |
18 |
56,727,647 |
56,732,431 |
RGD:6480464 |
CTD |
| G |
Rps18 |
ribosomal protein S18 |
|
affects expression |
EXP |
20 |
5,083,626 |
5,087,304 |
RGD:6480464 |
CTD |
| G |
Rps19 |
ribosomal protein S19 |
|
affects expression |
EXP |
1 |
80,176,649 |
80,182,351 |
RGD:6480464 |
CTD |
| G |
Rps20 |
ribosomal protein S20 |
|
affects expression |
EXP |
5 |
17,119,797 |
17,120,959 |
RGD:6480464 |
CTD |
| G |
Rps3a |
ribosomal protein S3a |
|
affects expression |
EXP |
2 |
178,092,351 |
178,096,720 |
RGD:6480464 |
CTD |
| G |
Rps6 |
ribosomal protein S6 |
|
affects expression |
EXP |
5 |
106,165,612 |
106,168,472 |
RGD:6480464 |
CTD |
| G |
Rps8 |
ribosomal protein S8 |
|
affects expression |
EXP |
5 |
137,466,705 |
137,469,275 |
RGD:6480464 |
CTD |
| G |
Rras2 |
related RAS viral (r-ras) oncogene homolog 2 |
|
affects expression |
EXP |
1 |
172,026,262 |
172,097,710 |
RGD:6480464 |
CTD |
| G |
RT1-S3 |
RT1 class Ib, locus S3 |
|
affects expression |
EXP |
20 |
2,815,943 |
2,820,644 |
RGD:6480464 |
CTD |
| G |
S1pr1 |
sphingosine-1-phosphate receptor 1 |
|
affects expression |
EXP |
2 |
211,851,304 |
211,855,511 |
RGD:6480464 |
CTD |
| G |
Sbspon |
somatomedin B and thrombospondin, type 1 domain containing |
|
affects expression |
EXP |
5 |
2,516,220 |
2,547,152 |
RGD:6480464 |
CTD |
| G |
Sdc2 |
syndecan 2 |
|
affects expression |
EXP |
7 |
68,290,558 |
68,405,183 |
RGD:6480464 |
CTD |
| G |
Sdhc |
succinate dehydrogenase complex, subunit C, integral membrane protein |
|
affects expression |
EXP |
13 |
87,014,569 |
87,035,239 |
RGD:6480464 |
CTD |
| G |
Sdhd |
succinate dehydrogenase complex, subunit D, integral membrane protein |
|
affects expression |
EXP |
8 |
53,955,067 |
53,964,547 |
RGD:6480464 |
CTD |
| G |
Serinc3 |
serine incorporator 3 |
|
affects expression |
EXP |
3 |
154,539,792 |
154,559,239 |
RGD:6480464 |
CTD |
| G |
Serpina1 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
|
affects expression |
EXP |
6 |
127,998,617 |
128,021,719 |
RGD:6480464 |
CTD |
| G |
Serpina10 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 |
|
affects expression |
EXP |
6 |
127,887,684 |
127,896,122 |
RGD:6480464 |
CTD |
| G |
Serpina4 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4 |
|
affects expression |
EXP |
6 |
128,133,692 |
128,142,768 |
RGD:6480464 |
CTD |
| G |
Serpinf2 |
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 |
|
affects expression |
EXP |
10 |
62,748,116 |
62,756,200 |
RGD:6480464 |
CTD |
| G |
Sfxn1 |
sideroflexin 1 |
|
affects expression |
EXP |
17 |
16,601,066 |
16,636,502 |
RGD:6480464 |
CTD |
| G |
Shmt2 |
serine hydroxymethyltransferase 2 (mitochondrial) |
|
affects expression |
EXP |
7 |
67,494,470 |
67,499,540 |
RGD:6480464 |
CTD |
| G |
Slc22a1 |
solute carrier family 22 (organic cation transporter), member 1 |
|
affects expression |
EXP |
1 |
42,351,239 |
42,378,295 |
RGD:6480464 |
CTD |
| G |
Slc22a12 |
solute carrier family 22 (organic anion/urate transporter), member 12 |
|
affects activity |
ISO |
1 |
209,320,804 |
209,327,918 |
RGD:6480464 |
CTD |
| G |
Slc22a12 |
solute carrier family 22 (organic anion/urate transporter), member 12 |
|
multiple interactions |
ISO |
1 |
209,320,804 |
209,327,918 |
RGD:6480464 |
CTD |
| G |
Slc22a12 |
solute carrier family 22 (organic anion/urate transporter), member 12 |
|
multiple interactions |
ISO |
1 |
209,320,804 |
209,327,918 |
RGD:6480464 |
CTD |
| G |
Slc22a12 |
solute carrier family 22 (organic anion/urate transporter), member 12 |
|
affects response to substance |
ISO |
1 |
209,320,804 |
209,327,918 |
RGD:6480464 |
CTD |
| G |
Slc22a12 |
solute carrier family 22 (organic anion/urate transporter), member 12 |
|
multiple interactions |
ISO |
1 |
209,320,804 |
209,327,918 |
RGD:6480464 |
CTD |
| G |
Slc22a12 |
solute carrier family 22 (organic anion/urate transporter), member 12 |
|
multiple interactions |
EXP |
1 |
209,320,804 |
209,327,918 |
RGD:6480464 |
CTD |
| G |
Slc22a12 |
solute carrier family 22 (organic anion/urate transporter), member 12 |
|
decreases activity |
ISO |
1 |
209,320,804 |
209,327,918 |
RGD:6480464 |
CTD |
| G |
Slc22a6 |
solute carrier family 22 (organic anion transporter), member 6 |
|
multiple interactions |
ISO |
1 |
211,294,178 |
211,302,398 |
RGD:6480464 |
CTD |
| G |
Slc23a1 |
solute carrier family 23 (nucleobase transporters), member 1 |
|
affects expression |
EXP |
18 |
28,238,953 |
28,250,889 |
RGD:6480464 |
CTD |
| G |
Slc25a13 |
solute carrier family 25 (aspartate/glutamate carrier), member 13 |
|
affects expression |
EXP |
4 |
30,822,456 |
31,006,241 |
RGD:6480464 |
CTD |
| G |
Slc25a3 |
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 3 |
|
affects expression |
EXP |
7 |
28,054,665 |
28,061,801 |
RGD:6480464 |
CTD |
| G |
Slc27a2 |
solute carrier family 27 (fatty acid transporter), member 2 |
|
affects expression |
EXP |
3 |
114,072,570 |
114,114,269 |
RGD:6480464 |
CTD |
| G |
Slc2a9 |
solute carrier family 2 (facilitated glucose transporter), member 9 |
|
multiple interactions |
ISO |
14 |
77,624,411 |
77,740,695 |
RGD:6480464 |
CTD |
| G |
Slc2a9 |
solute carrier family 2 (facilitated glucose transporter), member 9 |
|
multiple interactions |
ISO |
14 |
77,624,411 |
77,740,695 |
RGD:6480464 |
CTD |
| G |
Slc39a8 |
solute carrier family 39 (zinc transporter), member 8 |
|
affects expression |
EXP |
2 |
233,340,397 |
233,403,461 |
RGD:6480464 |
CTD |
| G |
Slc46a1 |
solute carrier family 46 (folate transporter), member 1 |
|
affects expression |
EXP |
10 |
64,576,068 |
64,582,504 |
RGD:6480464 |
CTD |
| G |
Slc6a6 |
solute carrier family 6 (neurotransmitter transporter, taurine), member 6 |
|
affects expression |
EXP |
4 |
125,875,817 |
125,945,795 |
RGD:6480464 |
CTD |
| G |
Slco1a1 |
solute carrier organic anion transporter family, member 1a1 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Sppl2a |
signal peptide peptidase-like 2A |
|
affects expression |
EXP |
3 |
114,428,234 |
114,469,506 |
RGD:6480464 |
CTD |
| G |
Srm |
spermidine synthase |
|
affects expression |
EXP |
5 |
165,672,516 |
165,675,673 |
RGD:6480464 |
CTD |
| G |
Srprb |
signal recognition particle receptor, B subunit |
|
affects expression |
EXP |
8 |
108,196,684 |
108,210,631 |
RGD:6480464 |
CTD |
| G |
Ssx2ip |
synovial sarcoma, X breakpoint 2 interacting protein |
|
affects expression |
EXP |
2 |
244,604,360 |
244,637,562 |
RGD:6480464 |
CTD |
| G |
St3gal6 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 6 |
|
affects expression |
EXP |
11 |
42,893,712 |
42,937,792 |
RGD:6480464 |
CTD |
| G |
St6gal1 |
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 |
|
affects expression |
EXP |
11 |
79,723,269 |
79,765,645 |
RGD:6480464 |
CTD |
| G |
Suclg1 |
succinate-CoA ligase, alpha subunit |
|
affects expression |
EXP |
4 |
106,572,140 |
106,601,495 |
RGD:6480464 |
CTD |
| G |
Surf4 |
surfeit 4 |
|
affects expression |
EXP |
3 |
5,817,200 |
5,830,060 |
RGD:6480464 |
CTD |
| G |
Synj2bp |
synaptojanin 2 binding protein |
|
affects expression |
EXP |
6 |
105,352,102 |
105,389,779 |
RGD:6480464 |
CTD |
| G |
Tgfbi |
transforming growth factor, beta induced |
|
affects expression |
EXP |
17 |
13,904,882 |
13,935,110 |
RGD:6480464 |
CTD |
| G |
Thnsl2 |
threonine synthase-like 2 (S. cerevisiae) |
|
affects expression |
EXP |
4 |
104,329,517 |
104,348,465 |
RGD:6480464 |
CTD |
| G |
Timm21 |
translocase of inner mitochondrial membrane 21 homolog (yeast) |
|
affects expression |
EXP |
18 |
81,524,258 |
81,528,720 |
RGD:6480464 |
CTD |
| G |
Tmbim1 |
transmembrane BAX inhibitor motif containing 1 |
|
affects expression |
EXP |
9 |
73,614,825 |
73,632,005 |
RGD:6480464 |
CTD |
| G |
Tmco1 |
transmembrane and coiled-coil domains 1 |
|
affects expression |
EXP |
13 |
82,971,926 |
82,995,262 |
RGD:6480464 |
CTD |
| G |
Tmed2 |
transmembrane emp24 domain trafficking protein 2 |
|
affects expression |
EXP |
12 |
33,165,291 |
33,174,326 |
RGD:6480464 |
CTD |
| G |
Tmed7 |
transmembrane emp24 protein transport domain containing 7 |
|
affects expression |
EXP |
18 |
40,800,887 |
40,808,002 |
RGD:6480464 |
CTD |
| G |
Tmem123 |
transmembrane protein 123 |
|
affects expression |
EXP |
8 |
4,604,130 |
4,632,932 |
RGD:6480464 |
CTD |
| G |
Tmem97 |
transmembrane protein 97 |
|
affects expression |
EXP |
10 |
64,652,641 |
64,661,724 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Txn1 |
thioredoxin 1 |
|
affects expression |
EXP |
5 |
75,921,365 |
75,933,595 |
RGD:6480464 |
CTD |
| G |
Txnl1 |
thioredoxin-like 1 |
|
affects expression |
EXP |
18 |
59,823,127 |
59,849,853 |
RGD:6480464 |
CTD |
| G |
Uba52 |
ubiquitin A-52 residue ribosomal protein fusion product 1 |
|
affects expression |
EXP |
16 |
19,425,401 |
19,427,557 |
RGD:6480464 |
CTD |
| G |
Ube2n |
ubiquitin-conjugating enzyme E2N |
|
affects expression |
EXP |
7 |
32,719,959 |
32,750,002 |
RGD:6480464 |
CTD |
| G |
Ufd1l |
ubiquitin fusion degradation 1 like (yeast) |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ugt1a1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
affects expression |
EXP |
9 |
87,091,241 |
87,098,362 |
RGD:6480464 |
CTD |
| G |
Uhrf1bp1l |
UHRF1 binding protein 1-like |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Uqcr11 |
ubiquinol-cytochrome c reductase, complex III subunit XI |
|
affects expression |
EXP |
7 |
10,816,422 |
10,821,051 |
RGD:6480464 |
CTD |
| G |
Vnn1 |
vanin 1 |
|
affects expression |
EXP |
1 |
22,087,290 |
22,097,592 |
RGD:6480464 |
CTD |
| G |
Wdr26 |
WD repeat domain 26 |
|
affects expression |
EXP |
13 |
96,944,266 |
96,984,348 |
RGD:6480464 |
CTD |
| G |
Ywhag |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide |
|
affects expression |
EXP |
12 |
21,859,804 |
21,888,050 |
RGD:6480464 |
CTD |
| G |
Zdhhc23 |
zinc finger, DHHC-type containing 23 |
|
affects expression |
EXP |
11 |
58,286,189 |
58,296,769 |
RGD:6480464 |
CTD |
benzyl bromide
|
| G |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
|
increases expression |
ISO |
13 |
41,308,286 |
41,312,190 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1r2 |
interleukin 1 receptor, type II |
|
increases expression |
ISO |
9 |
39,279,397 |
39,319,672 |
RGD:6480464 |
CTD |
| G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
|
increases expression |
ISO |
18 |
62,914,845 |
62,918,832 |
RGD:6480464 |
CTD |
bromfenac
|
| G |
Abcb11 |
ATP-binding cassette, subfamily B (MDR/TAP), member 11 |
|
decreases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
decreases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
bromobenzene
|
| G |
Abcc3 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 3 |
|
increases expression |
EXP |
10 |
82,986,552 |
83,030,799 |
RGD:6480464 |
CTD |
| G |
Abcc8 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 8 |
|
decreases expression |
EXP |
1 |
96,622,574 |
96,703,723 |
RGD:6480464 |
CTD |
| G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
decreases expression |
EXP |
16 |
49,036,892 |
49,081,416 |
RGD:6480464 |
CTD |
| G |
Actb |
actin, beta |
|
increases expression |
EXP |
12 |
12,047,070 |
12,050,040 |
RGD:6480464 |
CTD |
| G |
Actn4 |
actinin alpha 4 |
|
decreases expression |
EXP |
1 |
84,000,723 |
84,073,767 |
RGD:6480464 |
CTD |
| G |
Akr1c14 |
aldo-keto reductase family 1, member C14 |
|
affects binding |
EXP |
17 |
77,316,456 |
77,332,903 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
affects binding |
EXP |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
increases expression |
EXP |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
affects binding |
EXP |
1 |
223,731,675 |
223,773,285 |
RGD:6480464 |
CTD |
| G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
increases expression |
EXP |
1 |
223,731,675 |
223,773,285 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
affects binding |
EXP |
12 |
36,081,778 |
36,116,445 |
RGD:6480464 |
CTD |
| G |
Aldh9a1 |
aldehyde dehydrogenase 9 family, member A1 |
|
affects binding |
EXP |
13 |
83,017,312 |
83,034,047 |
RGD:6480464 |
CTD |
| G |
Ambp |
alpha-1-microglobulin/bikunin precursor |
|
increases expression |
EXP |
5 |
80,119,742 |
80,129,962 |
RGD:6480464 |
CTD |
| G |
Apoc3 |
apolipoprotein C-III |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Apoh |
apolipoprotein H (beta-2-glycoprotein I) |
|
increases expression |
EXP |
10 |
97,725,088 |
97,739,213 |
RGD:6480464 |
CTD |
| G |
Apom |
apolipoprotein M |
|
increases expression |
EXP |
20 |
3,754,604 |
3,757,204 |
RGD:6480464 |
CTD |
| G |
Arg1 |
arginase, liver |
|
affects binding |
EXP |
1 |
20,998,894 |
21,011,275 |
RGD:6480464 |
CTD |
| G |
Asf1a |
ASF1 anti-silencing function 1 homolog A (S. cerevisiae) |
|
increases expression |
EXP |
20 |
32,261,624 |
32,276,470 |
RGD:6480464 |
CTD |
| G |
Bhmt |
betaine-homocysteine S-methyltransferase |
|
decreases expression |
EXP |
2 |
23,923,651 |
23,943,320 |
RGD:6480464 |
CTD |
| G |
Bhmt |
betaine-homocysteine S-methyltransferase |
|
increases expression |
EXP |
2 |
23,923,651 |
23,943,320 |
RGD:6480464 |
CTD |
| G |
C1r |
complement component 1, r subcomponent |
|
decreases expression |
EXP |
4 |
160,712,582 |
160,729,362 |
RGD:6480464 |
CTD |
| G |
C9 |
complement component 9 |
|
decreases expression |
EXP |
2 |
55,743,084 |
55,791,148 |
RGD:6480464 |
CTD |
| G |
Capn1 |
calpain 1, (mu/I) large subunit |
|
decreases expression |
EXP |
1 |
208,620,286 |
208,645,007 |
RGD:6480464 |
CTD |
| G |
Car3 |
carbonic anhydrase 3 |
|
affects binding |
EXP |
2 |
88,106,727 |
88,114,686 |
RGD:6480464 |
CTD |
| G |
Cdc34 |
cell division cycle 34 |
|
increases expression |
EXP |
7 |
11,534,543 |
11,539,941 |
RGD:6480464 |
CTD |
| G |
Cdo1 |
cysteine dioxygenase, type I |
|
decreases expression |
EXP |
18 |
40,914,028 |
40,928,671 |
RGD:6480464 |
CTD |
| G |
Cdo1 |
cysteine dioxygenase, type I |
|
increases expression |
EXP |
18 |
40,914,028 |
40,928,671 |
RGD:6480464 |
CTD |
| G |
Cebpd |
CCAAT/enhancer binding protein (C/EBP), delta |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cfl1 |
cofilin 1, non-muscle |
|
increases expression |
EXP |
1 |
208,133,876 |
208,137,408 |
RGD:6480464 |
CTD |
| G |
Cltb |
clathrin, light chain B |
|
increases expression |
EXP |
17 |
16,063,715 |
16,081,277 |
RGD:6480464 |
CTD |
| G |
Csad |
cysteine sulfinic acid decarboxylase |
|
increases expression |
EXP |
7 |
140,917,995 |
140,944,405 |
RGD:6480464 |
CTD |
| G |
Csnk2b |
casein kinase 2, beta polypeptide |
|
increases expression |
EXP |
20 |
3,764,565 |
3,768,985 |
RGD:6480464 |
CTD |
| G |
Ctsl1 |
cathepsin L1 |
|
increases expression |
EXP |
17 |
6,288,013 |
6,294,174 |
RGD:6480464 |
CTD |
| G |
Cyb5a |
cytochrome b5 type A (microsomal) |
|
increases expression |
EXP |
18 |
81,415,972 |
81,452,606 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
increases expression |
EXP |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
decreases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
affects expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
decreases expression |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
1 |
81,266,828 |
81,290,471 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases expression |
EXP |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
|
decreases expression |
EXP |
1 |
243,281,320 |
243,320,945 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases expression |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases expression |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
|
decreases expression |
EXP |
12 |
17,164,384 |
17,204,589 |
RGD:6480464 |
CTD |
| G |
Cyp4a3 |
cytochrome P450, family 4, subfamily a, polypeptide 3 |
|
increases expression |
EXP |
5 |
135,876,140 |
135,893,753 |
RGD:6480464 |
CTD |
| G |
Cyp51 |
cytochrome P450, family 51 |
|
decreases expression |
EXP |
4 |
26,752,677 |
26,771,131 |
RGD:6480464 |
CTD |
| G |
Ddt |
D-dopachrome tautomerase |
|
affects binding |
EXP |
20 |
13,591,785 |
13,594,256 |
RGD:6480464 |
CTD |
| G |
Eci1 |
enoyl-CoA delta isomerase 1 |
|
increases expression |
EXP |
10 |
13,683,000 |
13,697,179 |
RGD:6480464 |
CTD |
| G |
Eif3c |
eukaryotic translation initiation factor 3, subunit C |
|
increases expression |
EXP |
1 |
185,691,630 |
185,709,514 |
RGD:6480464 |
CTD |
| G |
Eif5a |
eukaryotic translation initiation factor 5A |
|
increases expression |
EXP |
10 |
56,760,289 |
56,764,689 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
increases expression |
EXP |
13 |
96,722,973 |
96,752,940 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
increases expression |
EXP |
13 |
96,722,973 |
96,752,940 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
increases expression |
EXP |
13 |
96,722,973 |
96,752,940 |
RGD:6480464 |
CTD |
| G |
Fabp1 |
fatty acid binding protein 1, liver |
|
decreases expression |
EXP |
4 |
104,412,200 |
104,415,981 |
RGD:6480464 |
CTD |
| G |
Fabp1 |
fatty acid binding protein 1, liver |
|
affects binding |
EXP |
4 |
104,412,200 |
104,415,981 |
RGD:6480464 |
CTD |
| G |
Fabp7 |
fatty acid binding protein 7, brain |
|
affects binding |
EXP |
20 |
36,812,518 |
36,816,050 |
RGD:6480464 |
CTD |
| G |
Fah |
fumarylacetoacetate hydrolase |
|
affects binding |
EXP |
1 |
140,851,975 |
140,876,187 |
RGD:6480464 |
CTD |
| G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
|
decreases expression |
EXP |
15 |
42,425,336 |
42,453,390 |
RGD:6480464 |
CTD |
| G |
Fgg |
fibrinogen gamma chain |
|
decreases expression |
EXP |
2 |
174,727,312 |
174,734,594 |
RGD:6480464 |
CTD |
| G |
Fgl1 |
fibrinogen-like 1 |
|
decreases expression |
EXP |
16 |
54,434,779 |
54,465,928 |
RGD:6480464 |
CTD |
| G |
Flii |
flightless I homolog (Drosophila) |
|
increases expression |
EXP |
10 |
46,860,271 |
46,874,196 |
RGD:6480464 |
CTD |
| G |
Flii |
flightless I homolog (Drosophila) |
|
increases expression |
EXP |
10 |
46,860,271 |
46,874,196 |
RGD:6480464 |
CTD |
| G |
Flii |
flightless I homolog (Drosophila) |
|
increases expression |
EXP |
10 |
46,860,271 |
46,874,196 |
RGD:6480464 |
CTD |
| G |
Fmo1 |
flavin containing monooxygenase 1 |
|
increases expression |
EXP |
13 |
78,503,770 |
78,536,359 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
decreases expression |
EXP |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fth1 |
ferritin, heavy polypeptide 1 |
|
increases expression |
EXP |
1 |
212,430,453 |
212,432,741 |
RGD:6480464 |
CTD |
| G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
increases expression |
EXP |
X |
160,186,450 |
160,192,316 |
RGD:6480464 |
CTD |
| G |
Gamt |
guanidinoacetate N-methyltransferase |
|
affects binding |
EXP |
7 |
10,959,990 |
10,962,720 |
RGD:6480464 |
CTD |
| G |
Gast |
gastrin |
|
decreases expression |
EXP |
10 |
89,273,628 |
89,276,192 |
RGD:6480464 |
CTD |
| G |
Gc |
group specific component |
|
increases expression |
EXP |
14 |
20,166,243 |
20,197,060 |
RGD:6480464 |
CTD |
| G |
Gc |
group specific component |
|
increases expression |
EXP |
14 |
20,166,243 |
20,197,060 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
increases expression |
ISO |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gclm |
glutamate cysteine ligase, modifier subunit |
|
increases expression |
EXP |
2 |
218,895,434 |
218,915,491 |
RGD:6480464 |
CTD |
| G |
Gfm1 |
G elongation factor, mitochondrial 1 |
|
increases expression |
EXP |
2 |
157,283,046 |
157,327,969 |
RGD:6480464 |
CTD |
| G |
Ghrhr |
growth hormone releasing hormone receptor |
|
decreases response to substance |
ISO |
4 |
84,135,530 |
84,148,503 |
RGD:6480464 |
CTD |
| G |
Glud1 |
glutamate dehydrogenase 1 |
|
increases activity |
EXP |
16 |
9,965,718 |
9,999,254 |
RGD:6480464 |
CTD |
| G |
Gnmt |
glycine N-methyltransferase |
|
affects binding |
EXP |
9 |
10,127,092 |
10,130,444 |
RGD:6480464 |
CTD |
| G |
Got1 |
glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1) |
|
increases expression |
EXP |
1 |
247,324,285 |
247,347,553 |
RGD:6480464 |
CTD |
| G |
Gpd1 |
glycerol-3-phosphate dehydrogenase 1 (soluble) |
|
affects binding |
EXP |
7 |
138,458,875 |
138,466,266 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
multiple interactions |
ISO |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
increases activity |
ISO |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
increases expression |
EXP |
6 |
99,372,418 |
99,376,230 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
increases expression |
EXP |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
increases expression |
EXP |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gsta3 |
glutathione S-transferase alpha 3 |
|
increases expression |
EXP |
9 |
20,005,570 |
20,032,031 |
RGD:6480464 |
CTD |
| G |
Gsta5 |
glutathione S-transferase alpha 5 |
|
increases expression |
EXP |
8 |
83,202,554 |
83,211,997 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
affects binding |
EXP |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
increases expression |
EXP |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstm2 |
glutathione S-transferase mu 2 |
|
affects binding |
EXP |
2 |
203,549,022 |
203,553,380 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
increases expression |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
decreases expression |
EXP |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Hba2 |
hemoglobin, alpha 2 |
|
decreases expression |
EXP |
10 |
15,570,930 |
15,571,773 |
RGD:6480464 |
CTD |
| G |
Hbb |
hemoglobin, beta |
|
affects binding |
EXP |
1 |
161,618,782 |
161,620,193 |
RGD:6480464 |
CTD |
| G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) |
|
decreases expression |
EXP |
2 |
51,737,090 |
51,754,583 |
RGD:6480464 |
CTD |
| G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) |
|
decreases expression |
EXP |
2 |
193,128,736 |
193,143,106 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Homer2 |
homer homolog 2 (Drosophila) |
|
increases expression |
EXP |
1 |
137,827,128 |
137,933,089 |
RGD:6480464 |
CTD |
| G |
Hrsp12 |
heat-responsive protein 12 |
|
affects binding |
EXP |
7 |
69,930,464 |
69,944,267 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
increases expression |
ISO |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
decreases expression |
EXP |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
EXP |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa8 |
heat shock 70kDa protein 8 |
|
affects binding |
EXP |
8 |
43,784,035 |
43,787,760 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
increases expression |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Idh1 |
isocitrate dehydrogenase 1 (NADP+), soluble |
|
affects binding |
EXP |
9 |
63,769,401 |
63,790,622 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
decreases expression |
EXP |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Itih4 |
inter-alpha-trypsin inhibitor heavy chain family, member 4 |
|
decreases expression |
EXP |
16 |
6,319,608 |
6,334,782 |
RGD:6480464 |
CTD |
| G |
Klc3 |
kinesin light chain 3 |
|
affects binding |
EXP |
1 |
78,912,047 |
78,915,767 |
RGD:6480464 |
CTD |
| G |
Lap3 |
leucine aminopeptidase 3 |
|
decreases expression |
EXP |
14 |
70,680,077 |
70,699,061 |
RGD:6480464 |
CTD |
| G |
Ldhb |
lactate dehydrogenase B |
|
decreases expression |
EXP |
4 |
180,061,567 |
180,079,473 |
RGD:6480464 |
CTD |
| G |
Lonp1 |
lon peptidase 1, mitochondrial |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
increases phosphorylation |
ISO |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mcpt2 |
mast cell protease 2 |
|
increases expression |
EXP |
15 |
34,556,079 |
34,558,413 |
RGD:6480464 |
CTD |
| G |
Metap2 |
methionyl aminopeptidase 2 |
|
increases expression |
EXP |
7 |
30,974,071 |
31,001,641 |
RGD:6480464 |
CTD |
| G |
Mif |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
|
affects binding |
EXP |
20 |
13,191,986 |
13,192,851 |
RGD:6480464 |
CTD |
| G |
Mprip |
myosin phosphatase Rho interacting protein |
|
increases expression |
EXP |
10 |
45,975,683 |
46,090,601 |
RGD:6480464 |
CTD |
| G |
Msmo1 |
methylsterol monooxygenase 1 |
|
decreases expression |
EXP |
16 |
26,698,324 |
26,716,247 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
EXP |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt4 |
metallothionein 4 |
|
increases expression |
EXP |
19 |
11,300,057 |
11,302,153 |
RGD:6480464 |
CTD |
| G |
Myo9b |
myosin IXb |
|
decreases expression |
EXP |
16 |
18,434,261 |
18,519,220 |
RGD:6480464 |
CTD |
| G |
Nes |
nestin |
|
increases expression |
EXP |
2 |
180,051,907 |
180,060,947 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
increases localization |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
increases expression |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nox4 |
NADPH oxidase 4 |
|
decreases expression |
EXP |
1 |
143,415,816 |
143,603,554 |
RGD:6480464 |
CTD |
| G |
Npm1 |
nucleophosmin (nucleolar phosphoprotein B23, numatrin) |
|
increases expression |
EXP |
10 |
18,051,990 |
18,062,714 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
EXP |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
affects response to substance |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
EXP |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
EXP |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nupr1 |
nuclear protein, transcriptional regulator, 1 |
|
decreases expression |
EXP |
1 |
185,770,310 |
185,772,313 |
RGD:6480464 |
CTD |
| G |
Orm1 |
orosomucoid 1 |
|
increases expression |
EXP |
5 |
80,325,042 |
80,328,194 |
RGD:6480464 |
CTD |
| G |
Oxct1 |
3-oxoacid CoA transferase 1 |
|
decreases expression |
EXP |
2 |
53,189,358 |
53,217,848 |
RGD:6480464 |
CTD |
| G |
Park7 |
parkinson protein 7 |
|
affects binding |
EXP |
5 |
168,050,149 |
168,061,616 |
RGD:6480464 |
CTD |
| G |
Pebp1 |
phosphatidylethanolamine binding protein 1 |
|
affects binding |
EXP |
12 |
40,491,393 |
40,495,593 |
RGD:6480464 |
CTD |
| G |
Pgk1 |
phosphoglycerate kinase 1 |
|
affects binding |
EXP |
X |
94,324,219 |
94,340,193 |
RGD:6480464 |
CTD |
| G |
Phlda1 |
pleckstrin homology-like domain, family A, member 1 |
|
increases expression |
EXP |
7 |
50,541,011 |
50,543,215 |
RGD:6480464 |
CTD |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
increases expression |
EXP |
12 |
22,078,629 |
22,097,301 |
RGD:6480464 |
CTD |
| G |
Prdx6 |
peroxiredoxin 6 |
|
affects binding |
EXP |
13 |
76,824,968 |
76,835,517 |
RGD:6480464 |
CTD |
| G |
Psma1 |
proteasome (prosome, macropain) subunit, alpha type 1 |
|
increases expression |
EXP |
1 |
172,237,763 |
172,248,782 |
RGD:6480464 |
CTD |
| G |
Psma3 |
proteasome (prosome, macropain) subunit, alpha type 3 |
|
increases expression |
EXP |
6 |
93,092,191 |
93,112,167 |
RGD:6480464 |
CTD |
| G |
Psmb3 |
proteasome (prosome, macropain) subunit, beta type 3 |
|
increases expression |
EXP |
10 |
86,452,533 |
86,459,616 |
RGD:6480464 |
CTD |
| G |
Psmb5 |
proteasome (prosome, macropain) subunit, beta type 5 |
|
increases expression |
EXP |
15 |
32,689,859 |
32,694,364 |
RGD:6480464 |
CTD |
| G |
Psmc3 |
proteasome (prosome, macropain) 26S subunit, ATPase 3 |
|
affects binding |
EXP |
3 |
75,413,567 |
75,418,948 |
RGD:6480464 |
CTD |
| G |
Psmc4 |
proteasome (prosome, macropain) 26S subunit, ATPase, 4 |
|
affects binding |
EXP |
1 |
83,151,149 |
83,159,464 |
RGD:6480464 |
CTD |
| G |
Psmc5 |
proteasome (prosome, macropain) 26S subunit, ATPase, 5 |
|
increases expression |
EXP |
10 |
95,650,987 |
95,656,921 |
RGD:6480464 |
CTD |
| G |
Psmd5 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 5 |
|
increases expression |
EXP |
3 |
13,861,844 |
13,879,127 |
RGD:6480464 |
CTD |
| G |
Psme1 |
proteasome (prosome, macropain) activator subunit 1 |
|
affects binding |
EXP |
15 |
33,712,892 |
33,715,769 |
RGD:6480464 |
CTD |
| G |
Ptma |
prothymosin alpha |
|
increases expression |
EXP |
9 |
85,291,203 |
85,295,242 |
RGD:6480464 |
CTD |
| G |
Pzp |
pregnancy-zone protein |
|
decreases expression |
EXP |
4 |
165,505,104 |
165,579,027 |
RGD:6480464 |
CTD |
| G |
Ran |
RAN, member RAS oncogene family |
|
increases expression |
EXP |
12 |
28,736,786 |
28,739,921 |
RGD:6480464 |
CTD |
| G |
RGD1307603 |
similar to hypothetical protein MGC37914 |
|
decreases expression |
EXP |
1 |
206,645,199 |
206,648,212 |
RGD:6480464 |
CTD |
| G |
RGD1309534 |
similar to RIKEN cDNA 4931406C07 |
|
affects binding |
EXP |
8 |
12,084,956 |
12,106,942 |
RGD:6480464 |
CTD |
| G |
RGD1565157 |
similar to testis-specific farnesyl pyrophosphate synthetase |
|
decreases expression |
EXP |
2 |
177,242,728 |
177,244,194 |
RGD:6480464 |
CTD |
| G |
Rgn |
regucalcin (senescence marker protein-30) |
|
affects binding |
EXP |
X |
13,037,171 |
13,052,846 |
RGD:6480464 |
CTD |
| G |
Rpl15 |
ribosomal protein L15 |
|
increases expression |
EXP |
15 |
9,082,190 |
9,085,473 |
RGD:6480464 |
CTD |
| G |
Rpl22 |
ribosomal protein L22 |
|
increases expression |
EXP |
5 |
169,557,840 |
169,564,566 |
RGD:6480464 |
CTD |
| G |
Rpl27a |
ribosomal protein L27a |
|
increases expression |
EXP |
1 |
167,115,389 |
167,118,407 |
RGD:6480464 |
CTD |
| G |
Rpl35 |
ribosomal protein L35 |
|
increases expression |
EXP |
3 |
18,787,991 |
18,790,952 |
RGD:6480464 |
CTD |
| G |
Rpl35 |
ribosomal protein L35 |
|
decreases expression |
EXP |
3 |
18,787,991 |
18,790,952 |
RGD:6480464 |
CTD |
| G |
Rps11 |
ribosomal protein S11 |
|
increases expression |
EXP |
1 |
95,596,744 |
95,598,852 |
RGD:6480464 |
CTD |
| G |
Rps2 |
ribosomal protein S2 |
|
increases expression |
EXP |
10 |
13,975,350 |
13,977,199 |
RGD:6480464 |
CTD |
| G |
Rps26 |
ribosomal protein S26 |
|
increases expression |
EXP |
7 |
1,919,153 |
1,920,703 |
RGD:6480464 |
CTD |
| G |
Rps3a |
ribosomal protein S3a |
|
increases expression |
EXP |
2 |
178,092,351 |
178,096,720 |
RGD:6480464 |
CTD |
| G |
Rps6kb1 |
ribosomal protein S6 kinase, polypeptide 1 |
|
increases expression |
EXP |
10 |
76,657,024 |
76,698,088 |
RGD:6480464 |
CTD |
| G |
Rps8 |
ribosomal protein S8 |
|
increases expression |
EXP |
5 |
137,466,705 |
137,469,275 |
RGD:6480464 |
CTD |
| G |
Rrp9 |
ribosomal RNA processing 9, small subunit (SSU) processome component, homolog (yeast) |
|
decreases expression |
EXP |
8 |
111,621,968 |
111,630,963 |
RGD:6480464 |
CTD |
| G |
RT1-N1 |
RT1 class Ib, locus N1 |
|
increases expression |
EXP |
20 |
2,785,625 |
2,788,804 |
RGD:6480464 |
CTD |
| G |
RT1-N1 |
RT1 class Ib, locus N1 |
|
decreases expression |
EXP |
20 |
2,785,625 |
2,788,804 |
RGD:6480464 |
CTD |
| G |
Sbds |
Shwachman-Bodian-Diamond syndrome |
|
decreases expression |
EXP |
12 |
27,457,313 |
27,466,472 |
RGD:6480464 |
CTD |
| G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
|
decreases expression |
EXP |
1 |
249,458,860 |
249,471,460 |
RGD:6480464 |
CTD |
| G |
Selenbp1 |
selenium binding protein 1 |
|
affects binding |
EXP |
2 |
189,840,450 |
189,881,332 |
RGD:6480464 |
CTD |
| G |
Sepp1 |
selenoprotein P, plasma, 1 |
|
decreases expression |
EXP |
2 |
52,451,883 |
52,462,263 |
RGD:6480464 |
CTD |
| G |
Slc15a4 |
solute carrier family 15, member 4 |
|
increases expression |
EXP |
12 |
30,111,863 |
30,131,134 |
RGD:6480464 |
CTD |
| G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
affects binding |
EXP |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sord |
sorbitol dehydrogenase |
|
increases activity |
EXP |
3 |
109,016,830 |
109,048,446 |
RGD:6480464 |
CTD |
| G |
Sult1b1 |
sulfotransferase family, cytosolic, 1B, member 1 |
|
affects binding |
EXP |
14 |
22,019,193 |
22,031,914 |
RGD:6480464 |
CTD |
| G |
Sult1c3 |
sulfotransferase family, cytosolic, 1C, member 3 |
|
decreases expression |
EXP |
9 |
486,576 |
531,962 |
RGD:6480464 |
CTD |
| G |
Sult2a6 |
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 6 |
|
decreases expression |
EXP |
1 |
74,553,799 |
74,605,247 |
RGD:6480464 |
CTD |
| G |
Synj2 |
synaptojanin 2 |
|
decreases expression |
EXP |
1 |
40,763,794 |
40,818,491 |
RGD:6480464 |
CTD |
| G |
Taf9b |
TAF9B RNA polymerase II, TATA box binding protein (TBP)-associated factor |
|
increases expression |
EXP |
X |
94,342,071 |
94,351,927 |
RGD:6480464 |
CTD |
| G |
Tf |
transferrin |
|
decreases expression |
EXP |
8 |
108,217,774 |
108,244,487 |
RGD:6480464 |
CTD |
| G |
Thra |
thyroid hormone receptor alpha |
|
decreases expression |
EXP |
10 |
87,514,443 |
87,542,306 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Tmsb10 |
thymosin, beta 10 |
|
decreases expression |
EXP |
4 |
106,286,030 |
106,287,089 |
RGD:6480464 |
CTD |
| G |
Tpi1 |
triosephosphate isomerase 1 |
|
affects binding |
EXP |
4 |
160,933,341 |
160,936,871 |
RGD:6480464 |
CTD |
| G |
Tpm1 |
tropomyosin 1, alpha |
|
affects binding |
EXP |
8 |
71,331,304 |
71,358,063 |
RGD:6480464 |
CTD |
| G |
Tshr |
thyroid stimulating hormone receptor |
|
decreases expression |
EXP |
6 |
115,024,999 |
115,162,531 |
RGD:6480464 |
CTD |
| G |
Tshr |
thyroid stimulating hormone receptor |
|
increases expression |
EXP |
6 |
115,024,999 |
115,162,531 |
RGD:6480464 |
CTD |
| G |
Tuba1a |
tubulin, alpha 1A |
|
increases expression |
EXP |
7 |
137,729,405 |
137,733,071 |
RGD:6480464 |
CTD |
| G |
Tubb2b |
tubulin, beta 2B class IIb |
|
decreases expression |
EXP |
17 |
37,087,922 |
37,090,969 |
RGD:6480464 |
CTD |
| G |
Tubb4b |
tubulin, beta 4B class IVb |
|
increases expression |
EXP |
3 |
3,387,050 |
3,389,500 |
RGD:6480464 |
CTD |
| G |
Txn1 |
thioredoxin 1 |
|
affects binding |
EXP |
5 |
75,921,365 |
75,933,595 |
RGD:6480464 |
CTD |
| G |
Ubd |
ubiquitin D |
|
decreases expression |
EXP |
20 |
1,475,944 |
1,477,895 |
RGD:6480464 |
CTD |
| G |
Ugdh |
UDP-glucose 6-dehydrogenase |
|
affects binding |
EXP |
14 |
45,542,781 |
45,570,961 |
RGD:6480464 |
CTD |
| G |
Upb1 |
ureidopropionase, beta |
|
affects binding |
EXP |
20 |
13,715,995 |
13,743,261 |
RGD:6480464 |
CTD |
| G |
Vtn |
vitronectin |
|
decreases expression |
EXP |
10 |
64,609,242 |
64,612,322 |
RGD:6480464 |
CTD |
| G |
Ywhaq |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide |
|
decreases expression |
EXP |
6 |
41,945,769 |
41,976,123 |
RGD:6480464 |
CTD |
| G |
Ywhaz |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide |
|
decreases expression |
EXP |
7 |
72,283,825 |
72,306,126 |
RGD:6480464 |
CTD |
bromochloroacetic acid
|
| G |
Actb |
actin, beta |
|
increases expression |
ISO |
12 |
12,047,070 |
12,050,040 |
RGD:6480464 |
CTD |
| G |
Actg2 |
actin, gamma 2, smooth muscle, enteric |
|
decreases expression |
EXP |
4 |
117,732,482 |
117,747,006 |
RGD:6480464 |
CTD |
| G |
Actn1 |
actinin, alpha 1 |
|
decreases expression |
EXP |
6 |
103,188,593 |
103,282,873 |
RGD:6480464 |
CTD |
| G |
Actn4 |
actinin alpha 4 |
|
decreases expression |
EXP |
1 |
84,000,723 |
84,073,767 |
RGD:6480464 |
CTD |
| G |
Afp |
alpha-fetoprotein |
|
decreases expression |
ISO |
14 |
19,092,563 |
19,110,728 |
RGD:6480464 |
CTD |
| G |
Akt2 |
v-akt murine thymoma viral oncogene homolog 2 |
|
increases expression |
EXP |
1 |
82,686,233 |
82,726,544 |
RGD:6480464 |
CTD |
| G |
Arf4 |
ADP-ribosylation factor 4 |
|
decreases expression |
EXP |
16 |
1,955,745 |
1,972,321 |
RGD:6480464 |
CTD |
| G |
Bnip3l |
BCL2/adenovirus E1B interacting protein 3-like |
|
increases expression |
EXP |
15 |
46,516,626 |
46,539,756 |
RGD:6480464 |
CTD |
| G |
Cd34 |
CD34 molecule |
|
decreases expression |
ISO |
13 |
110,877,594 |
110,896,722 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
decreases expression |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdx2 |
caudal type homeo box 2 |
|
increases expression |
ISO |
12 |
8,296,103 |
8,303,643 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
decreases expression |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
decreases expression |
EXP |
4 |
29,393,645 |
29,428,572 |
RGD:6480464 |
CTD |
| G |
Col2a1 |
collagen, type II, alpha 1 |
|
decreases expression |
ISO |
7 |
136,679,219 |
136,707,976 |
RGD:6480464 |
CTD |
| G |
Crabp2 |
cellular retinoic acid binding protein 2 |
|
increases expression |
ISO |
2 |
180,029,801 |
180,034,147 |
RGD:6480464 |
CTD |
| G |
Ddx4 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 |
|
decreases expression |
ISO |
2 |
43,964,552 |
44,022,919 |
RGD:6480464 |
CTD |
| G |
Dnmt3b |
DNA (cytosine-5-)-methyltransferase 3 beta |
|
decreases expression |
ISO |
3 |
144,030,737 |
144,069,265 |
RGD:6480464 |
CTD |
| G |
Eef1a1 |
eukaryotic translation elongation factor 1 alpha 1 |
|
increases expression |
ISO |
8 |
83,463,591 |
83,466,813 |
RGD:6480464 |
CTD |
| G |
Eomes |
eomesodermin |
|
decreases expression |
ISO |
8 |
123,376,689 |
123,383,451 |
RGD:6480464 |
CTD |
| G |
Eras |
ES cell expressed Ras |
|
increases expression |
ISO |
X |
26,608,537 |
26,612,923 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
decreases expression |
EXP |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fat1 |
FAT tumor suppressor homolog 1 (Drosophila) |
|
decreases expression |
EXP |
16 |
50,472,074 |
50,591,399 |
RGD:6480464 |
CTD |
| G |
Fgf4 |
fibroblast growth factor 4 |
|
increases expression |
ISO |
1 |
205,292,272 |
205,293,705 |
RGD:6480464 |
CTD |
| G |
Fgf5 |
fibroblast growth factor 5 |
|
increases expression |
ISO |
14 |
12,713,971 |
12,734,634 |
RGD:6480464 |
CTD |
| G |
Flt1 |
FMS-related tyrosine kinase 1 |
|
decreases expression |
ISO |
12 |
7,858,092 |
8,035,966 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
increases expression |
ISO |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
decreases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fosl1 |
fos-like antigen 1 |
|
decreases expression |
EXP |
1 |
208,090,612 |
208,099,118 |
RGD:6480464 |
CTD |
| G |
Foxa2 |
forkhead box A2 |
|
affects expression |
ISO |
3 |
136,739,009 |
136,743,204 |
RGD:6480464 |
CTD |
| G |
Fzd2 |
frizzled family receptor 2 |
|
decreases expression |
EXP |
10 |
91,709,222 |
91,711,132 |
RGD:6480464 |
CTD |
| G |
Gabrb3 |
gamma-aminobutyric acid (GABA) A receptor, beta 3 |
|
affects expression |
ISO |
1 |
109,047,399 |
109,277,756 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
decreases expression |
EXP |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gal |
galanin/GMAP prepropeptide |
|
increases expression |
ISO |
1 |
205,936,352 |
205,941,215 |
RGD:6480464 |
CTD |
| G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
increases expression |
ISO |
4 |
161,282,215 |
161,286,090 |
RGD:6480464 |
CTD |
| G |
Gata6 |
GATA binding protein 6 |
|
increases expression |
ISO |
18 |
2,504,264 |
2,534,648 |
RGD:6480464 |
CTD |
| G |
Gbx2 |
gastrulation brain homeobox 2 |
|
increases expression |
ISO |
9 |
89,034,340 |
89,037,102 |
RGD:6480464 |
CTD |
| G |
Gcm1 |
glial cells missing homolog 1 (Drosophila) |
|
increases expression |
ISO |
8 |
83,018,975 |
83,032,211 |
RGD:6480464 |
CTD |
| G |
Gdf3 |
growth differentiation factor 3 |
|
increases expression |
ISO |
4 |
159,064,054 |
159,067,854 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
decreases expression |
ISO |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gnaq |
guanine nucleotide binding protein (G protein), q polypeptide |
|
decreases expression |
EXP |
1 |
219,520,998 |
219,764,401 |
RGD:6480464 |
CTD |
| G |
Grb7 |
growth factor receptor bound protein 7 |
|
increases expression |
ISO |
10 |
87,252,571 |
87,261,619 |
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
affects expression |
EXP |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Hbz |
hemoglobin, zeta |
|
increases expression |
ISO |
10 |
15,590,914 |
15,592,386 |
RGD:6480464 |
CTD |
| G |
Hlxb9 |
homeobox gene HB9 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Iapp |
islet amyloid polypeptide |
|
decreases expression |
ISO |
4 |
179,855,956 |
179,860,871 |
RGD:6480464 |
CTD |
| G |
Ifitm1 |
interferon induced transmembrane protein 1 |
|
increases expression |
ISO |
1 |
201,154,494 |
201,155,509 |
RGD:6480464 |
CTD |
| G |
Ifitm2 |
interferon induced transmembrane protein 2 |
|
decreases expression |
ISO |
1 |
201,134,357 |
201,135,537 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
increases expression |
EXP |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
|
increases expression |
EXP |
9 |
71,966,877 |
71,994,211 |
RGD:6480464 |
CTD |
| G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
|
increases expression |
ISO |
9 |
71,966,877 |
71,994,211 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
increases expression |
EXP |
14 |
87,959,153 |
87,967,085 |
RGD:6480464 |
CTD |
| G |
Igfbp6 |
insulin-like growth factor binding protein 6 |
|
increases expression |
EXP |
7 |
140,885,388 |
140,890,028 |
RGD:6480464 |
CTD |
| G |
Il6st |
interleukin 6 signal transducer |
|
increases expression |
ISO |
2 |
43,806,301 |
43,842,365 |
RGD:6480464 |
CTD |
| G |
Ilk |
integrin-linked kinase |
|
decreases expression |
EXP |
1 |
163,481,299 |
163,487,550 |
RGD:6480464 |
CTD |
| G |
Ins2 |
insulin 2 |
|
decreases expression |
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:6480464 |
CTD |
| G |
Itga8 |
integrin, alpha 8 |
|
decreases expression |
EXP |
17 |
86,427,191 |
86,649,268 |
RGD:6480464 |
CTD |
| G |
Itgb1 |
integrin, beta 1 |
|
decreases expression |
EXP |
19 |
58,600,095 |
58,647,531 |
RGD:6480464 |
CTD |
| G |
Itgb2 |
integrin, beta 2 |
|
increases expression |
EXP |
20 |
11,446,521 |
11,485,009 |
RGD:6480464 |
CTD |
| G |
Kit |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
|
decreases expression |
ISO |
14 |
34,906,043 |
34,984,819 |
RGD:6480464 |
CTD |
| G |
Krt1 |
keratin 1 |
|
decreases expression |
ISO |
7 |
140,540,960 |
140,546,186 |
RGD:6480464 |
CTD |
| G |
Lama1 |
laminin, alpha 1 |
|
increases expression |
ISO |
9 |
106,855,708 |
106,980,651 |
RGD:6480464 |
CTD |
| G |
Lamb1 |
laminin, beta 1 |
|
decreases expression |
ISO |
6 |
49,115,671 |
49,183,374 |
RGD:6480464 |
CTD |
| G |
Lamc1 |
laminin, gamma 1 |
|
increases expression |
ISO |
13 |
68,241,453 |
68,369,419 |
RGD:6480464 |
CTD |
| G |
Lefty1 |
left right determination factor 1 |
|
affects expression |
ISO |
13 |
96,664,408 |
96,667,805 |
RGD:6480464 |
CTD |
| G |
Lefty2 |
Left-right determination factor 2 |
|
increases expression |
ISO |
13 |
96,621,422 |
96,626,509 |
RGD:6480464 |
CTD |
| G |
Lifr |
leukemia inhibitory factor receptor alpha |
|
increases expression |
ISO |
2 |
56,426,058 |
56,477,198 |
RGD:6480464 |
CTD |
| G |
Mapkapk2 |
mitogen-activated protein kinase-activated protein kinase 2 |
|
increases expression |
EXP |
13 |
43,994,943 |
44,041,504 |
RGD:6480464 |
CTD |
| G |
Msln |
mesothelin |
|
increases expression |
EXP |
10 |
15,017,162 |
15,022,823 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
increases expression |
EXP |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myf5 |
myogenic factor 5 |
|
decreases expression |
ISO |
7 |
46,189,256 |
46,192,487 |
RGD:6480464 |
CTD |
| G |
Myod1 |
myogenic differentiation 1 |
|
decreases expression |
ISO |
1 |
96,910,190 |
96,912,900 |
RGD:6480464 |
CTD |
| G |
Nanog |
Nanog homeobox |
|
increases expression |
ISO |
4 |
159,190,786 |
159,198,160 |
RGD:6480464 |
CTD |
| G |
Neurod1 |
neuronal differentiation 1 |
|
increases expression |
ISO |
3 |
62,224,633 |
62,227,936 |
RGD:6480464 |
CTD |
| G |
Nodal |
nodal growth differentiation factor |
|
affects expression |
ISO |
20 |
29,546,982 |
29,555,419 |
RGD:6480464 |
CTD |
| G |
Nog |
noggin |
|
increases expression |
ISO |
10 |
77,689,244 |
77,690,871 |
RGD:6480464 |
CTD |
| G |
Nov |
nephroblastoma overexpressed |
|
decreases expression |
EXP |
7 |
91,162,676 |
91,169,696 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide A |
|
increases expression |
ISO |
5 |
165,074,518 |
165,075,827 |
RGD:6480464 |
CTD |
| G |
Nr5a2 |
nuclear receptor subfamily 5, group A, member 2 |
|
increases expression |
ISO |
13 |
49,931,592 |
50,048,756 |
RGD:6480464 |
CTD |
| G |
Nras |
neuroblastoma ras oncogene |
|
increases expression |
EXP |
2 |
198,292,650 |
198,300,286 |
RGD:6480464 |
CTD |
| G |
Olig2 |
oligodendrocyte lineage transcription factor 2 |
|
decreases expression |
ISO |
11 |
31,205,416 |
31,208,792 |
RGD:6480464 |
CTD |
| G |
Pax6 |
paired box 6 |
|
increases expression |
ISO |
3 |
91,127,605 |
91,149,178 |
RGD:6480464 |
CTD |
| G |
Podxl |
podocalyxin-like |
|
increases expression |
ISO |
4 |
58,611,904 |
58,658,598 |
RGD:6480464 |
CTD |
| G |
Pou5f1 |
POU class 5 homeobox 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ppp1r12a |
protein phosphatase 1, regulatory subunit 12A |
|
decreases expression |
EXP |
7 |
46,876,552 |
46,986,022 |
RGD:6480464 |
CTD |
| G |
Ppp2r2b |
protein phosphatase 2, regulatory subunit B, beta |
|
increases expression |
EXP |
18 |
35,865,837 |
36,318,308 |
RGD:6480464 |
CTD |
| G |
Prkcz |
protein kinase C, zeta |
|
increases expression |
EXP |
5 |
172,061,825 |
172,172,793 |
RGD:6480464 |
CTD |
| G |
Rala |
v-ral simian leukemia viral oncogene homolog A (ras related) |
|
decreases expression |
EXP |
17 |
55,017,444 |
55,030,555 |
RGD:6480464 |
CTD |
| G |
Rest |
RE1-silencing transcription factor |
|
decreases expression |
ISO |
14 |
33,136,046 |
33,151,142 |
RGD:6480464 |
CTD |
| G |
Sema3a |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
|
decreases expression |
ISO |
4 |
17,575,112 |
17,790,100 |
RGD:6480464 |
CTD |
| G |
Sfrp2 |
secreted frizzled-related protein 2 |
|
decreases expression |
ISO |
2 |
175,479,320 |
175,486,865 |
RGD:6480464 |
CTD |
| G |
Sox17 |
SRY (sex determining region Y)-box 17 |
|
decreases expression |
ISO |
5 |
15,241,405 |
15,246,904 |
RGD:6480464 |
CTD |
| G |
Sox2 |
SRY (sex determining region Y)-box 2 |
|
affects expression |
ISO |
2 |
120,969,021 |
120,971,430 |
RGD:6480464 |
CTD |
| G |
Sst |
somatostatin |
|
increases expression |
ISO |
11 |
79,125,031 |
79,126,216 |
RGD:6480464 |
CTD |
| G |
Sycp3 |
synaptonemal complex protein 3 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Syp |
synaptophysin |
|
decreases expression |
ISO |
X |
26,890,307 |
26,905,319 |
RGD:6480464 |
CTD |
| G |
T |
brachyury |
|
increases expression |
ISO |
1 |
46,937,223 |
46,944,988 |
RGD:6480464 |
CTD |
| G |
Tat |
tyrosine aminotransferase |
|
decreases expression |
ISO |
19 |
39,854,163 |
39,865,060 |
RGD:6480464 |
CTD |
| G |
Tdgf1 |
teratocarcinoma-derived growth factor 1 |
|
increases expression |
ISO |
8 |
115,341,587 |
115,346,871 |
RGD:6480464 |
CTD |
| G |
Tert |
telomerase reverse transcriptase |
|
increases expression |
ISO |
1 |
30,445,180 |
30,465,942 |
RGD:6480464 |
CTD |
| G |
Tgfb2 |
transforming growth factor, beta 2 |
|
decreases expression |
EXP |
13 |
102,718,703 |
102,818,768 |
RGD:6480464 |
CTD |
| G |
Tgfb3 |
transforming growth factor, beta 3 |
|
decreases expression |
EXP |
6 |
110,173,443 |
110,195,215 |
RGD:6480464 |
CTD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
increases expression |
EXP |
8 |
120,593,595 |
120,680,453 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
affects expression |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Wnt4 |
wingless-type MMTV integration site family, member 4 |
|
increases expression |
EXP |
5 |
156,064,371 |
156,083,198 |
RGD:6480464 |
CTD |
| G |
Wt1 |
Wilms tumor 1 |
|
decreases expression |
ISO |
3 |
90,529,704 |
90,577,280 |
RGD:6480464 |
CTD |
| G |
Zfp42 |
zinc finger protein 42 |
|
increases expression |
ISO |
16 |
52,150,048 |
52,158,306 |
RGD:6480464 |
CTD |
bromoform
|
| G |
Gabra1 |
gamma-aminobutyric acid (GABA) A receptor, alpha 1 |
|
multiple interactions |
ISO |
10 |
27,258,813 |
27,313,725 |
RGD:6480464 |
CTD |
| G |
Gabrb2 |
gamma-aminobutyric acid (GABA) A receptor, beta 2 |
|
multiple interactions |
ISO |
10 |
27,602,085 |
27,819,145 |
RGD:6480464 |
CTD |
| G |
Gabrg2 |
gamma-aminobutyric acid (GABA) A receptor, gamma 2 |
|
multiple interactions |
ISO |
10 |
27,037,561 |
27,126,074 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
decreases methylation |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
ISO |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
bromomethane
|
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
increases metabolic processing |
ISO |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
bromosulfophthalein
|
| G |
Abcb4 |
ATP-binding cassette, subfamily B (MDR/TAP), member 4 |
|
affects transport |
EXP |
4 |
21,946,274 |
22,004,328 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
affects export |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gsta1 |
glutathione S-transferase alpha 1 |
|
multiple interactions |
ISO |
9 |
20,051,501 |
20,068,146 |
RGD:6480464 |
CTD |
| G |
Gsta1 |
glutathione S-transferase alpha 1 |
|
affects binding |
ISO |
9 |
20,051,501 |
20,068,146 |
RGD:6480464 |
CTD |
| G |
Gsta3 |
glutathione S-transferase alpha 3 |
|
decreases activity |
EXP |
9 |
20,005,570 |
20,032,031 |
RGD:6480464 |
CTD |
| G |
Gstm2 |
glutathione S-transferase mu 2 |
|
decreases activity |
EXP |
2 |
203,549,022 |
203,553,380 |
RGD:6480464 |
CTD |
| G |
Hgf |
hepatocyte growth factor |
|
multiple interactions |
EXP |
4 |
14,864,357 |
14,932,513 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12B |
|
multiple interactions |
ISO |
10 |
29,558,955 |
29,568,331 |
RGD:6480464 |
CTD |
| G |
Keap1 |
Kelch-like ECH-associated protein 1 |
|
decreases glutathionylation |
ISO |
8 |
20,259,178 |
20,266,351 |
RGD:6480464 |
CTD |
| G |
Keap1 |
Kelch-like ECH-associated protein 1 |
|
decreases transport |
ISO |
8 |
20,259,178 |
20,266,351 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
affects abundance |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
increases glutathionylation |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
increases transport |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Slc19a1 |
solute carrier family 19 (folate transporter), member 1 |
|
multiple interactions |
EXP |
20 |
11,984,283 |
12,001,865 |
RGD:6480464 |
CTD |
| G |
Slc19a1 |
solute carrier family 19 (folate transporter), member 1 |
|
decreases activity |
EXP |
20 |
11,984,283 |
12,001,865 |
RGD:6480464 |
CTD |
| G |
Slc22a24 |
solute carrier family 22, member 24 |
|
multiple interactions |
EXP |
1 |
210,409,224 |
210,465,549 |
RGD:6480464 |
CTD |
| G |
Slc22a6 |
solute carrier family 22 (organic anion transporter), member 6 |
|
multiple interactions |
ISO |
1 |
211,294,178 |
211,302,398 |
RGD:6480464 |
CTD |
| G |
Slc22a7 |
solute carrier family 22 (organic anion transporter), member 7 |
|
multiple interactions |
ISO |
9 |
9,934,309 |
9,940,107 |
RGD:6480464 |
CTD |
| G |
Slc22a8 |
solute carrier family 22 (organic anion transporter), member 8 |
|
multiple interactions |
EXP |
1 |
211,269,366 |
211,287,596 |
RGD:6480464 |
CTD |
| G |
Slc46a1 |
solute carrier family 46 (folate transporter), member 1 |
|
multiple interactions |
ISO |
10 |
64,576,068 |
64,582,504 |
RGD:6480464 |
CTD |
| G |
Slc46a1 |
solute carrier family 46 (folate transporter), member 1 |
|
decreases activity |
ISO |
10 |
64,576,068 |
64,582,504 |
RGD:6480464 |
CTD |
| G |
Slc46a1 |
solute carrier family 46 (folate transporter), member 1 |
|
multiple interactions |
EXP |
10 |
64,576,068 |
64,582,504 |
RGD:6480464 |
CTD |
| G |
Slco1a1 |
solute carrier organic anion transporter family, member 1a1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Slco1b3 |
solute carrier organic anion transporter family, member 1b3 |
|
affects import |
ISO |
4 |
179,045,586 |
179,118,680 |
RGD:6480464 |
CTD |
| G |
Slco1b3 |
solute carrier organic anion transporter family, member 1b3 |
|
multiple interactions |
ISO |
4 |
179,045,586 |
179,118,680 |
RGD:6480464 |
CTD |
| G |
Slco1b3 |
solute carrier organic anion transporter family, member 1b3 |
|
increases response to substance |
ISO |
4 |
179,045,586 |
179,118,680 |
RGD:6480464 |
CTD |
| G |
Slco1b3 |
solute carrier organic anion transporter family, member 1b3 |
|
multiple interactions |
ISO |
4 |
179,045,586 |
179,118,680 |
RGD:6480464 |
CTD |
| G |
Slco1b3 |
solute carrier organic anion transporter family, member 1b3 |
|
multiple interactions |
ISO |
4 |
179,045,586 |
179,118,680 |
RGD:6480464 |
CTD |
| G |
Slco1b3 |
solute carrier organic anion transporter family, member 1b3 |
|
increases uptake |
ISO |
4 |
179,045,586 |
179,118,680 |
RGD:6480464 |
CTD |
| G |
Slco2b1 |
solute carrier organic anion transporter family, member 2b1 |
|
affects import |
ISO |
1 |
156,992,492 |
157,028,887 |
RGD:6480464 |
CTD |
| G |
Slco2b1 |
solute carrier organic anion transporter family, member 2b1 |
|
multiple interactions |
ISO |
1 |
156,992,492 |
157,028,887 |
RGD:6480464 |
CTD |
| G |
Slco2b1 |
solute carrier organic anion transporter family, member 2b1 |
|
increases uptake |
ISO |
1 |
156,992,492 |
157,028,887 |
RGD:6480464 |
CTD |
brompheniramine
|
| G |
Kcnh2 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
|
decreases activity |
ISO |
4 |
6,192,644 |
6,224,285 |
RGD:6480464 |
CTD |
| G |
Kcnh2 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
|
decreases activity |
ISO |
4 |
6,192,644 |
6,224,285 |
RGD:6480464 |
CTD |
| G |
Scn5a |
sodium channel, voltage-gated, type V, alpha subunit |
|
decreases activity |
ISO |
8 |
124,446,479 |
124,545,301 |
RGD:6480464 |
CTD |
dibromomethane
|
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
multiple interactions |
ISO |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
affects metabolic processing |
ISO |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
multiple interactions |
EXP |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
affects metabolic processing |
EXP |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
monobromobimane
|
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
affects metabolic processing |
ISO |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
naled
|
| G |
Ache |
acetylcholinesterase |
|
decreases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
decreases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apeh |
N-acylaminoacyl-peptide hydrolase |
|
decreases activity |
ISO |
8 |
113,353,151 |
113,362,263 |
RGD:6480464 |
CTD |
| G |
Apeh |
N-acylaminoacyl-peptide hydrolase |
|
decreases activity |
ISO |
8 |
113,353,151 |
113,362,263 |
RGD:6480464 |
CTD |
NAN 190 hydrobromide
|
| G |
Htr1a |
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled |
|
multiple interactions |
ISO |
2 |
36,434,518 |
36,435,786 |
RGD:6480464 |
CTD |
| G |
Htr1a |
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled |
|
multiple interactions |
EXP |
2 |
36,434,518 |
36,435,786 |
RGD:6480464 |
CTD |
| G |
Htr1a |
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled |
|
multiple interactions |
ISO |
2 |
36,434,518 |
36,435,786 |
RGD:6480464 |
CTD |
phenacyl bromide
|
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
multiple interactions |
ISO |
12 |
36,081,778 |
36,116,445 |
RGD:6480464 |
CTD |
potassium bromate
|
| G |
Apex1 |
APEX nuclease (multifunctional DNA repair enzyme) 1 |
|
increases expression |
ISO |
15 |
26,904,124 |
26,906,224 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated |
|
decreases expression |
ISO |
8 |
56,894,746 |
56,996,565 |
RGD:6480464 |
CTD |
| G |
Brca1 |
breast cancer 1, early onset |
|
increases expression |
ISO |
10 |
90,513,630 |
90,572,676 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
increases expression |
ISO |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
multiple interactions |
ISO |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccno |
cyclin O |
|
decreases expression |
ISO |
2 |
44,377,953 |
44,381,020 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
increases phosphorylation |
ISO |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
increases expression |
EXP |
15 |
45,365,779 |
45,405,314 |
RGD:6480464 |
CTD |
| G |
Ercc4 |
excision repair cross-complementing rodent repair deficiency, complementation group 4 |
|
decreases expression |
ISO |
10 |
2,144,262 |
2,177,554 |
RGD:6480464 |
CTD |
| G |
Fen1 |
flap structure-specific endonuclease 1 |
|
decreases expression |
ISO |
1 |
212,688,118 |
212,692,486 |
RGD:6480464 |
CTD |
| G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
|
increases mutagenesis |
ISO |
X |
139,929,647 |
139,961,616 |
RGD:6480464 |
CTD |
| G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
|
increases mutagenesis |
ISO |
X |
139,929,647 |
139,961,616 |
RGD:6480464 |
CTD |
| G |
Lig3 |
ligase III, DNA, ATP-dependent |
|
decreases expression |
ISO |
10 |
71,000,287 |
71,021,398 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mutyh |
mutY homolog (E. coli) |
|
decreases expression |
ISO |
5 |
137,103,958 |
137,115,897 |
RGD:6480464 |
CTD |
| G |
Pnkp |
polynucleotide kinase 3'-phosphatase |
|
decreases expression |
ISO |
1 |
95,330,455 |
95,335,468 |
RGD:6480464 |
CTD |
| G |
Srxn1 |
sulfiredoxin 1 |
|
increases expression |
ISO |
3 |
142,457,352 |
142,462,725 |
RGD:6480464 |
CTD |
| G |
Tk1 |
thymidine kinase 1, soluble |
|
increases mutagenesis |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Top3b |
topoisomerase (DNA) III beta |
|
decreases expression |
ISO |
11 |
86,116,936 |
86,145,314 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases phosphorylation |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases phosphorylation |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Xrcc3 |
X-ray repair complementing defective repair in Chinese hamster cells 3 |
|
decreases expression |
ISO |
6 |
136,594,276 |
136,602,069 |
RGD:6480464 |
CTD |
sodium bromide
|
| G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
|
multiple interactions |
ISO |
16 |
19,046,200 |
19,056,281 |
RGD:6480464 |
CTD |
tralomethrin
|
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
vecuronium bromide
|
| G |
Chrm1 |
cholinergic receptor, muscarinic 1 |
|
multiple interactions |
ISO |
1 |
211,351,738 |
211,353,120 |
RGD:6480464 |
CTD |
| G |
Chrm2 |
cholinergic receptor, muscarinic 2 |
|
multiple interactions |
ISO |
4 |
63,911,292 |
63,913,354 |
RGD:6480464 |
CTD |
| G |
Chrm3 |
cholinergic receptor, muscarinic 3 |
|
multiple interactions |
ISO |
17 |
71,214,906 |
71,218,463 |
RGD:6480464 |
CTD |
| G |
Chrm4 |
cholinergic receptor, muscarinic 4 |
|
multiple interactions |
ISO |
3 |
76,301,988 |
76,309,729 |
RGD:6480464 |
CTD |
| G |
Chrm5 |
cholinergic receptor, muscarinic 5 |
|
multiple interactions |
ISO |
3 |
98,326,809 |
98,378,531 |
RGD:6480464 |
CTD |
| G |
Chrna3 |
cholinergic receptor, nicotinic, alpha 3 (neuronal) |
|
multiple interactions |
ISO |
8 |
58,570,223 |
58,583,594 |
RGD:6480464 |
CTD |
| G |
Chrna4 |
cholinergic receptor, nicotinic, alpha 4 (neuronal) |
|
multiple interactions |
ISO |
3 |
170,171,214 |
170,185,998 |
RGD:6480464 |
CTD |
| G |
Chrna4 |
cholinergic receptor, nicotinic, alpha 4 (neuronal) |
|
multiple interactions |
ISO |
3 |
170,171,214 |
170,185,998 |
RGD:6480464 |
CTD |
| G |
Chrna7 |
cholinergic receptor, nicotinic, alpha 7 (neuronal) |
|
multiple interactions |
ISO |
1 |
117,587,580 |
117,716,267 |
RGD:6480464 |
CTD |
| G |
Chrnb2 |
cholinergic receptor, nicotinic, beta 2 (neuronal) |
|
multiple interactions |
ISO |
2 |
181,961,373 |
181,969,581 |
RGD:6480464 |
CTD |
| G |
Chrnb2 |
cholinergic receptor, nicotinic, beta 2 (neuronal) |
|
multiple interactions |
ISO |
2 |
181,961,373 |
181,969,581 |
RGD:6480464 |
CTD |
| G |
Chrnb4 |
cholinergic receptor, nicotinic, beta 4 (neuronal) |
|
multiple interactions |
ISO |
8 |
58,586,961 |
58,605,545 |
RGD:6480464 |
CTD |
| G |
Hexb |
hexosaminidase B |
|
increases secretion |
ISO |
2 |
27,649,188 |
27,672,231 |
RGD:6480464 |
CTD |
Term paths to the root
|